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ABSTRACT 
 
Some leucine-rich repeat (LRR) -containing membrane proteins are known regulators of neuronal 
growth and synapse formation. In this work I characterize two gene families encoding neuronal LRR 
membrane proteins, namely the LRRTM (leucine-rich repeat, transmembrane neuronal) and NGR 
(Nogo-66 receptor) families. 
 
I studied LRRTM and NGR family member’s mRNA tissue distribution by RT-PCR and by in situ 
hybridization. Subcellular localization of LRRTM1 protein was studied in neurons and in non-
neuronal cells. I discovered that LRRTM and NGR family mRNAs are predominantly expressed in 
the nervous system, and that each gene possesses a specific expression pattern. I also established 
that LRRTM and NGR family mRNAs are expressed by neurons, and not by glial cells. Within 
neurons, LRRTM1 protein is not transported to the plasma membrane; rather it localizes to 
endoplasmic reticulum. 
 
Nogo-A (RTN4), MAG, and OMgp are myelin-associated proteins that bind to NgR1 to limit axonal 
regeneration after central nervous system injury. To better understand the functions of NgR2 and 
NgR3, and to explore the possible redundancy in the signaling of myelin inhibitors of neurite growth, I 
mapped the interactions between NgR family and the known and candidate NgR1 ligands. I identified 
high-affinity interactions between RTN2-66, RTN3-66 and NgR1. I also demonstrate that Rtn3 
mRNA is expressed in the same glial cell population of mouse spinal cord white matter as Nogo-A 
mRNA, and thus it could have a role in myelin inhibition of axonal growth. 
 
To understand how NgR1 interacts with multiple structurally divergent ligands, I aimed first to map in 
more detail the nature of Nogo-A:NgR1 interactions, and then to systematically map the binding sites 
of multiple myelin ligands in NgR1 by using a library of NgR1 expression constructs encoding  
proteins with one or multiple surface residues mutated to alanine. My analysis of the Nogo-A:NgR1 -
interactions revealed a novel interaction site between the proteins, suggesting a trivalent Nogo-
A:NgR1-interaction. Our analysis also defined a central binding region on the concave side of 
NgR1’s LRR domain that is required for the binding of all known ligands, and a surrounding region 
critical for binding MAG and OMgp. 
 
To better understand the biological role of LRRTMs, I generated Lrrtm1 and Lrrtm3 knock out mice. I 
show here that reporter genes expressed from the targeted loci can be used for maping the neuronal 
connections of Lrrtm1 and Lrrtm3 expressing neurons in finer detail.  
 
With regard to LRRTM1’s role in humans, we found a strong association between a 70 kb-spanning 
haplotype in the proposed promoter region of LRRTM1 gene and two possibly related phenotypes: 
left-handedness and schizophrenia. Interestingly, the responsible haplotype was linked to phenotypic 
variability only when paternally inherited.  
 
In summary, I identified two families of neuronal receptor-like proteins, and mapped their expression 
and certain protein-protein interactions. The identification of a central binding region in NgR1 shared 
by multiple ligands may facilitate the design and development of small molecule therapeutics 
blocking binding of all NgR1 ligands. Additionally, the genetic association data suggests that allelic 
variation upstream of LRRTM1 may play a role in the development of left-right brain asymmetry in 
humans. Lrrtm1 and Lrrtm3 knock out mice developed as a part of this study will likely be useful for 
schizophrenia and Alzheimer’s disease research. 
    1  
1 REVIEW OF THE LITERATURE  
 
 
1.1 Identifying protein-coding genes in 
the post-genomic era 
 
In 1977 Frederick Sanger introduced a method 
to sequence DNA, known currently as chain 
termination method or the Sanger method 
(Sanger et al. 1977), which was to become the 
method used in sequencing of the human 
genome. The International Human Genome 
Project (HGP) was launched in 1990 with the 
goal of obtaining a highly accurate sequence 
of the vast majority of the euchromatic portion 
of the human genome.  
 
The results of initial sequencing and analysis 
of the human genome were published in 
February 2001 by the International Human 
Genome Sequencing Consortium (IHGSC) 
(IHGSC 2001), and by Celera Genomics, Inc. 
(Venter et al. 2001). Both of these drafts 
lacked ~10% of the euchromatic sequence 
and ~30% of the genomic sequence as a 
whole. The authors of these studies suggested 
that the human genome harbors 30 000 – 
40 000 (IHGSC 2001) or 24 000 – 40 000 
(Venter et al. 2001) protein-coding genes. 
However, in October 2004 a more complete 
analysis of human genome, based on 
sequences covering ~99 % of the euchromatic 
sequence, led IHGCS to refine its estimate to 
20 000 – 25 000 protein-coding genes (IHGSC 
2004). Currently (build August 2006, database 
version 42.36d) the Ensembl human genome 
database (Hubbard et al. 2007) contains 21 
774 protein-coding genes. The CCDS 
(consensus coding sequence) database 
contains protein-coding genes that different 
organizations involved in gene annotation 
agree to a single amino acid level. These 
CCDS contributors are European 
Bioinformatics Institute (EBI), National Center 
for Biotechnology Information (NCBI), 
Wellcome Trust Sanger Institute (WTSI), and 
University of California, Santa Cruz (UCSC)). 
In early 2007 CCDS contained only 13 132 
genes (CCDS 2007). 
 
The above mentioned numbers for protein-
coding genes illustrate the iterative process of 
human genome analysis. The variation of the 
protein-coding gene number estimates, 
although converging by nature, also 
underscores the need for non-automatic 
curation of gene annotation and experimental 
verification of the proposed genes, and thus 
warranted our efforts that led to the cloning 
and characterization of LRRTM (leucine-rich 
repeat transmembrane neuronal) and NGRL 
(Nogo-66 receptor like) gene families.  
 
The very recent changes in gene number 
estimates (e.g. March, 2006 build of Ensembl 
human genome database contained 21 561 
protein-coding genes vs. the current 21 774 
genes, as stated above) illustrate that the 
efforts to exhaustively catalogue the protein-
coding genes in the human genome are still 
needed and ongoing. 
  
In the recent years, efforts to identify protein-
coding genes have been based on the 
following methods (Brent 2005): 
 
•  Analysis of expressed sequence tag 
(EST) cDNA clones. This historically 
successful approach provides direct 
experimental evidence for mRNA 
transcripts (Boguski et al. 1993). 
However, it is limited by the fact that as 
more and more transcripts are already 
known, it has became increasingly 
unlikely to identify novel transcripts 
perhaps expressed only in a small sub-
set of cells in an organism. On Jan. 12th, 
2007 NCBI’s dbEST-database 
contained ~8x106 EST sequences 
derived from human cDNA libraries. 
 
•  Genomic sequence database searches 
for homologous sequences. This 
enables identification of genes 
homologous to known genes. TBLASTN 
search tool, which performs conceptual 
translation of the searched nucleotide 
databases, is commonly used (Gish and 
States 1993). Additionally, using 
homology searches orthologous genes 
in other organisms can be identified as 
well.    
 
• Aligning genomic sequences from 
multiple organisms. As the protein-
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coding regions are more conserved than 
non-coding regions of the genome, the 
analysis of sequence conservation 
between species allows identification of 
protein-coding genes. This approach is, 
however complicated by non-protein-
coding functional elements of the 
genome, which also display 
considerable or even extreme sequence 
conservation between species 
(Bejerano et al. 2004).  
 
• Identifying genes based on their 
sequence composition. An example of 
computer programs using this approach 
is GenScan (Burge and Karlin 1997). 
GenScan identifies putative genes 
based on their characteristic 
transcriptional, translational and splicing 
signals, as well as typical features of 
exons, introns and intergenic regions.  
 
These methods, plus manual annotation, are 
usually used in combination  to come up with 
the best predictions (Brent 2005). However, 
the predicted gene structures should be 
experimentally verified (Brent 2005).   
 
 
1.2 The zeitgeist of ’omics’ vs. bottom-
up approaches in biology 
 
The challenges of genome analysis are even 
significantly larger in areas other than 
identification of protein-coding genes. Since 
the discovery of non-protein coding 
transcribed DNA, the very definition of gene 
has been under debate (Pearson 2006). 
Identification of all genes satisfying the current 
suggested all-encompassing definition of a 
gene – a locatable region of genomic 
sequence corresponding to a unit of 
inheritance, which is associated with 
regulatory regions, transcribed regions and/or 
other functional sequence regions – provides 
an even greater challenge (Pearson 2006). 
However, efforts to identify all functional non-
protein-coding transcripts, as well as other 
regulatory elements in the human genome are 
ongoing (ENCODE 2004).  
 
Sequencing the human genome arguably 
paved the way for other large-scale projects in 
biology. Hence, the ‘-ome’ and ‘-omics’ -
suffixes in ‘genome’ and ‘genomics’ were 
adapted into a short-hand notations e.g. for 
proteome and epigenome, the entity of all the 
proteins and all DNA modifications, 
respectively.  
 
A notable example of current significant large-
scale projects in biology is the HapMap 
project, which has already elucidated the 
common single nucleotide polymorphisms 
(SNPs) in the certain human populations 
(HapMap_Consortium 2005). 
 
The databases containing the results of the 
human and mouse genome projects and the 
HapMap database were used in this thesis 
work. The availability of genomic sequences 
was instrumental in gene identification, and 
the availability of HapMap data facilitated the 
study on the role of LRRTM1 locus 
polymorphism in humans. Thus, results from 
large-scale projects can greatly benefit 
numerous smaller-scale projects that aim to 
understand biology by working the way ‘from 
bottom to up’, from individual details towards 
overall understanding of the system’s 
functions. 
 
In contrast, other large-scale projects seem 
likely to render certain current scientific 
practices either obsolete or forces them to 
define a new niche that provides raison d’être. 
A recent example of this development is the 
Allen Brain Atlas, which provides a well-
accessible cellular-resolution, genome-wide 
map of gene expression in the mouse brain 
(Lein et al. 2007). Currently, this digital atlas 
contains ~1x106 images and provides mouse 
brain expression data obtained by in situ 
hybridization with probes targeting ~20 000 
genes. The data in Allen Brain Atlas is 
consistent with what I have reported for 
LRRTM and NGR gene families (I, II, and 
unpublished data). The Allen Brain Atlas 
reduces the need to perform in situ 
hybridizations to more specific situations, e.g. 
as was also done in this work when i) I 
assessed the developmental expression of 
Lrrtm1 in mouse brain structures relevant for 
Schizophrenia pathogenesis (IV), and ii) when 
I assessed the expression of reticulon (RTN) 
family mRNA transcript splice variants 
containing the RTN homology domain (RHD) 
in adult mouse spinal cord white matter (III).  
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Arguably, certain types of projects are less 
amenable to automation and offer lesser 
economies of scale than others. The 
productivity of work at dedicated genome 
sequencing centers rose sharply during the 
human genome project (IHGSC 2001). The 
proposed project to generate a knock out 
mouse model for every protein-coding gene, 
on the other hand, has had only moderate 
success, and the projected goal of the project 
for the years 2006 – 2010 is to generate in 
total 920 new knock out mouse lines. 
(The_International_Mouse_Knockout_Consorti
um 2007). This represents only 4% of protein-
coding genes in the mouse genome. Because 
of the expected limited output, the project 
participants have agreed to prioritize which 
genes to knock out first. Also, the possibility to 
create null, hypomorphic, or conditional knock 
outs seems likely to drive demand for custom-
designed knock out mice for years to come. 
The current fragmentary model to generate 
knock out mice may even remain as the 
mainstream method. We generated Lrrtm1 
and Lrrtm3 knock out mice lines during this 
thesis work. These genes have not been 
currently targeted by the large scale mouse 
knock out projects. 
 
In summary, based on the examples given 
above, the large-scale ‘omic’ projects have 
greatly benefited the biological inquiry, but 
‘from bottom to up’, or hypothesis-driven 
approaches to biological inquiry seem likely to 
prevail for the time being. This thesis 
illustrates well the challenges biological 
research faces when trying to find a balance 
between gene-driven and genome-driven 
biological paradigms. Clearly the ongoing 
large-scale data-driven projects need to be 
supported with more advanced data storage 
and annotation systems than the current 
format of printed scientific publications. 
 
 
1.3 How to elucidate what a gene does: 
from gene to phenotype or vice versa? 
 
Traditionally functions of genes have been 
studied by means of “forward genetics” (from 
phenotype to gene). In the field of medical 
genetics this positional cloning of gene defects 
underlying hereditary phenotypes was greatly 
accelerated by advanced maps of the human 
genome, and similar approaches have also 
been used to map gene variants underlying 
mouse phenotypes (Takahashi et al. 1994). In 
mouse and other model organisms these 
efforts were also accelerated by the possibility 
to create random mutations. Analogously, 
forward genetic approaches are used to 
manipulate the DNA content of individual cells, 
followed by identification of the cells displaying 
the desired phenotype. This is then, again, 
followed by the identification of DNA changes 
that induced the phenotype (Stark and Gudkov 
1999). Examples of cell-based “forward 
genetics” approaches are various two-hybrid 
screenings, and expression cloning strategies 
to identify cell surface receptors (see e.g. 
(Fournier et al. 2001)). 
 
The genome projects and other simultaneous 
efforts to analyze genomic sequences led to 
the identification of a great number of genes 
without known functions (IHGSC 2001). An 
example is my discovery of LRRTM and NGRL 
gene families.  A plausible approach to study 
the functions of these functionally orphan 
genes would combine bioinformatics, 
molecular and cell biology methods, and 
analysis of genetically engineered model 
organisms. Since no information about gene’s 
function is available in the beginning of the 
study, this approach necessarily includes a 
‘leap of faith’ that something biologically 
important will be discovered.  
 
This dichotomist view to elucidate gene’s 
functions has evolved; reverse and forward 
genetic approaches can be considered as 
complementary. As the positional cloning 
efforts to identify gene variants predisposing to 
multifactorial diseases have largely failed 
(Hirschhorn and Daly 2005), the reverse 
genetics approach could reveal important 
insights into the functions of the candidate 
genes and hence strengthen or weaken the 
evidence linking variation in a certain gene to 
a certain phenotypic trait. This interdisciplinary 
approach was used in this thesis work when 
analyzing the role of LRRTM1 gene in the 
determination of handedness and 
schizophrenia susceptibility (IV). 
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1.4 The leucine-rich repeat protein 
superfamily  
 
The LRRTM and NGRL gene families 
described in this work encode proteins with 
leucine-rich repeat (LRR) domains as a 
dominant feature.  
1.4.1 Structure of the LRR domain 
 
Leucine-rich repeats consist of 20–29 amino 
acid long repetitive sequences with a variable 
segment and a more conserved segment, 
defined by a consensus sequence 
LxxLxLxxNxL, or LxxLxLxxCxxL, in which “L” 
is Val, Leu, or Ile, “N” is Asn, Thr, Ser, or Cys, 
and “C” is Cys or Ser (Kobe and Kajava 2001; 
Enkhbayar et al. 2004). LRRs are present in a 
tandem fashion, varying in known cases from 
2 to 45 repeats (Enkhbayar et al. 2004). An 
uninterrupted set of LRRs is referred as a LRR 
domain. Based on variation in the variable 
region, LRRs are classified into seven 
subfamilies, the most common being named 
as a “typical” subfamily (Enkhbayar et al. 
2004). The LRR domain in LRRTM and NGRL 
family members belongs to this “typical” 
subfamily. Typically in LRR proteins destined 
for the extracellular/secretory pathway, the 
amino- and carboxyl-terminal LRRs are 
flanked by cysteine-rich flanking domains 
(LRRNT and LRRCT, respectively). The 
typically four cysteines in flanking domains 
form two disulphide bond pairs. By shielding 
the otherwise exposed hydrophobic core at the 
ends of the LRRs, these capping domains 
serve essential functions in the folding of the 
LRR domain. These capping modules are 
usually classified as being a part of the LRR 
domain (Kobe and Kajava 2001).  
 
Individual LRRs correspond to basic structural 
units in the LRR domain. Each unit consists of 
a β strand and adjacent loop regions (which 
corresponds to the conserved segment in the 
consensus sequence), and an α helix or less 
orderly loop structure (which corresponds to 
the more variable segment in the consensus 
sequence). β strands are aligned in a parallel 
fashion on the concave side of the LRR 
domain whereas α helix or loop structures are 
located on the convex side. The LRR domain 
forms a non-globular, more or less curved 
structure (Figure 1). In addition to curving 
around a single axis (arc or also called as 
banana, or horseshoe shape) some LRRs 
show some degree of twist around another 
axis. The extended shape of LRR domain 
offers opportunities for molecular interactions 
(Kobe and Kajava 2001).  
 
 
 
 
Figure 1. Crystal structure of NgR1 (A) and LINGO-1 
(B) Ectodomains. β-sheets are visualized with yellow 
arrows, and α-helical structures are shown in green. 
Observed carbohydrate moieties are also shown. For 
NgR1 the structure contains only LRR domain, whereas 
the structure of Lingo-1 encompasses LRR and IgG-like 
domains. The illustrations were done using Cn3D 4.1 
software (NCBI), and they are based on the atomic 
coordinate files  deposited to NCBI Structure database: 
1P8T (human NgR1 (Barton et al. 2003)) and 2ID5 
(human LINGO-1 (Mosyak et al. 2006)). NgR1 and 
LINGO1 are not in same scale. 
 
 
Biochemical experiments have demonstrated 
that several LRR proteins show homophilic 
adhesion or heterophilic adhesion among 
family members (Fournier et al. 2002; Kuja-
Panula et al. 2003; Karaulanov et al. 2006); 
these findings are supported and possibly 
mechanistically explained by the observed 
packing of LRR protein monomers into crystals 
used for determining the structure of NgR1 
and LINGO-1 (Barton et al. 2003; Mosyak et 
al. 2006).  
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1.4.2 Prevalence of the LRR domains in the 
proteome 
 
Genes encoding LRR domain-containing 
proteins are present in eukaryotes and 
prokaryotes. InterPro  (Mulder et al. 2007) 
database contains 14 functionally 
uncharacterized LRR proteins from Archaea 
(e.g. proteins with UniProt database accession 
numbers: Q2NHF7, Q648Z4 and Q8TNI4) 
Interestingly, in plants, LRR-containing 
receptor-like kinases (RLKs) compose a large 
family of proteins (216 members in A. 
thaliana). Each RLK encompasses an 
extracellular LRR domain, a transmembrane 
segment, and a cytoplasmic serine/threonine 
protein kinase domain. RLKs have diverse 
roles in transduction of extracellular signals to 
cells (Dievart and Clark 2004). In jawless 
vertebrates the variable lymphocyte receptors 
consist of LRRs. Analogously to 
immunoglobulin-type antigen receptors in 
other vertebrates, the somatic diversification of 
these lymphocyte receptors occurs by random 
selection and assembly of LRRs (Alder et al. 
2005).  
 
As of January 2007 InterPro database 
contained 571 entries (genes) encoding 
proteins with LRR domain(s). As InterPro 
database of protein families, domains and 
functional sites combines data from multiple 
sources, it provides the current best estimate 
for the prevalence of this domain. Thus, ~2% 
of human proteins have LRR domain. 
However, it should be noted that currently 
InterPro database does not exhaustively cover 
the entire human transcriptome (Mulder et al. 
2007). Therefore, although the exact number 
of LRR-encoding proteins is currently unclear, 
it is likely close to 571, making the LRR 
domain undoubtedly a very commonly 
occurring protein domain in human proteome.  
 
 
Gene/ gene family Expression 
pattern 
Subcellular protein 
localization 
Protein structure Biological functions Selected 
reference 
 
Toll-like receptor 
(TLR) family (11 
members) 
immune cells 
  
plasma membrane, 
endosomes  
LRR domain, TM segment, 
intracellular part 
Innate immunity (recognition of 
microbial components) 
(Akira et al. 
2006) 
Polycystin1  widely expressed 
plasma membrane, 
endoplasmic 
reticulum 
large extracellular region with 
several domains (incl. LRR), 11 
membrane-spanning segments, 
cytoplasmic G protein binding site 
Forms a Ca-ion channel; other 
functions; mutations cause 
autosomal dominant polycystic 
kidney disease (ADPKD). 
(Ong and Harris 
2005) 
Leucine-rich repeat-
containing G protein 
coupled receptors 
(GPCR), (LGRs) (8 
members) 
widely 
expressed; 
differs between 
family members 
plasma membrane 
extracellular LRR domain -
containing G protein coupled 
receptors (GPCRs) 
Glycoprotein hormone receptors: 
luteinizing hormone (LH), follicle-
stimulating hormone (FSH), and 
thyroid-stimulating hormone (TSH) 
receptors, LGR4-8 orphan 
receptors 
(Hsu et al. 2000) 
Small leucine-rich 
repeat 
proteoglycans 
(SLRPs) (at least 
nine members) 
differs between 
family members extracellular matrix 
LRR domain, attached 
glycosaminoglycan moieties 
Regulate cell growth, adhesion, 
and migration 
(Hocking et al. 
1998) 
Scribble widely expressed 
cytoplasm and 
nucleus 
LRR domain, multiple C-terminal 
PDZ domains 
Regulates cell polarity and 
differentiation; potential tumor 
suppressor gene 
(Navarro et al. 
2005) 
Platelet 
glygoprotein Ib α 
megakaryo-
blasts, platelets plasma membrane 
LRR domain, TM segment, 
intracellular part Platelet adhesion 
(Huizinga et al. 
2002) 
Slit family (3 
members) 
predominantly 
neuronal  extracellular matrix 
complex domain architecture; N-
terminal LRR domain is critical for 
receptor binding 
Signal via Robo receptors to guide 
axonal growth and angiogenesis 
(Wong et al. 
2002) 
LRRK family (2 
members)  
predominantly 
neuronal cytoplasmic 
LRR, GTPase, COR, kinase, and 
WD40 domains 
LRRK2 is the most commonly 
mutated gene in autosomal 
dominant Parkinson’s disease 
(Mata et al. 
2006) 
LGI family (4 
members) 
predominantly 
neuronal secreted 
LRR domain and a EPTP repeat 
region 
Enhances AMPA receptor-
mediated synaptic transmission; 
mutated in autosomal dominant 
lateral temporal epilepsy (ADLTE) 
(Fukata et al. 
2006) 
Neuronal type I TM 
or GPI-anchored 
proteins 
predominantly 
neuronal 
plasma membrane, 
secretory pathway see Table 2 see Table 2 see Table 2 
 
Table 1. Examples of human proteins with LRR domain. LRRK, leucine-rich repeat kinase; COR, C-terminal of 
Roc; EPTP 
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Selected examples of human LRR proteins 
are shown in Table 1. Examples were 
selected to illustrate the diverse roles LRR 
domain containing proteins serve. The table 
also exemplifies that LRRs are present in 
secreted proteins, in proteins spanning the 
plasma membrane or other cellular lipid 
bilayers, and in intracellular proteins. Not 
surprisingly, many genes encoding LRR 
proteins are mutated in known human 
diseases (for review, see (Matsushima et al. 
2005)).  
 
Bases on sequence homology, LRRTM and 
NGR families belong to the most populated 
“typical” subfamily of LRR proteins. In 
humans, according to the InterPro database, 
this subfamily has 257 annotated members. 
1.4.3 On the evolution of genes encoding 
proteins with signal peptide and LRR 
domain  
 
The family of genes encoding signal-peptide 
containing LRR proteins seems to have 
expanded dramatically since the divergence 
of vertebrate and arthropod lineages: I 
identified 12 Drosophila melanogaster genes 
encoding LRR domain and signal  peptide 
from UniprotKB database 
(Uniprot_Consortium 2007), whereas 100 
human entries satisfied the same criteria. 
These numbers are, however, not absolute, 
as annotation of signal peptides for some 
entries (for those derived from trEMBL 
database) depends on whether the original 
data submitter annotated that feature or not 
(Dr. Nicky Mulder, European Bioinformatics 
Institute, personal communication). 
Nonetheless, assuming that the fruit fly 
genome is at least as well annotated as that 
of humans, these numbers demonstrate the 
rapid expansion of LRR membrane protein 
family during vertebrate evolution. Literature 
analysis based on the identified fruit fly 
proteins shows that many of these proteins, 
recognized by database and additional 
literature searches, possess a 
transmembrane (TM) segment, in addition to 
LRR domain and signal peptide, and 
possibly an IgG-like domain. Well 
characterized examples are capricious  and 
tartan (signal peptide, 14 LRRs, TM 
segment, short intracellular region) (Milan et 
al. 2001) and kekkon family members (6 
genes encoding proteins with seven LRRs, 
IgG-like domain, TM segment and a short 
intracellular region) (MacLaren et al. 2004). 
Capricious and tartan have a role in 
regulating cell adhesion (Milan et al. 2001), 
and kekkon-1 negatively regulates the 
activity of the drosophila EGF (epidermal 
growth factor) receptor (Ghiglione et al. 
1999).  
 
Given the rapid expansion of LRR 
membrane proteins during vertebrate 
evolution, invertebrate orthologs for specific 
vertebrate LRR membrane proteins can 
generally not be determined unambiguously 
using sequence homology analysis. In 
contrast, due to the sequence conservation 
of LRR proteins during vertebrate evolution 
(e.g. (Kuja-Panula et al. 2003), I, II), the 
paralogs belonging to a particular family of 
vertebrate LRR proteins can usually be 
determined.  
 
 
1.5 Neuronal LRR membrane proteins 
 
Literature analysis of vertebrate genes 
encoding proteins with signal peptide, LRR 
domain, and TM segment/GPI anchor shows 
that in most known cases, these genes are 
highly expressed in the nervous system. 
This prominently neuronal expression 
pattern has been noticed earlier (Chen et al. 
2006). By analyzing protein databanks in 
conjunction with exhaustive literature 
searches I identified 41 human genes 
satisfying the following criteria: i) has a 
published reference verifying that the gene 
or a closely related family member is 
neuronally expressed (i.e. all family 
members were included if at least one 
member of the family is known to be 
predominantly neuronally expressed); ii) 
presumably encodes a protein possessing a 
signal peptide, LRR domain, a single TM 
segment or GPI-anchor modification site, 
and optionally some additional domains. 
These 41 gene products are referred here 
as “neuronal LRR membrane proteins”, and 
they are listed in Table 2. For some genes 
encoding type I TM LRR proteins expression 
pattern is not established, and several 
genes are not characterized elsewhere than 
in bioinformatics databases. These genes 
are excluded from Table 2. Some genes 
 Review of the Literature  
      7 
encoding type I TM LRR proteins are clearly 
not neuronally expressed or enriched (most 
importantly toll-like receptor family (Akira et 
al. 2006)). 
 
Notably, the majority of LRR proteins do not 
contain transmembrane segments or GPI-
anchor modification sequences; they are 
either secreted or intracellular proteins. In 
these LRR protein subfamilies, a great 
diversity of domains occurs in tandem with 
LRR domain. 
1.5.1 Structural features of neuronal LRR 
membrane proteins 
 
Neuronal LRR membrane proteins typically 
contain ~10 LRRs (from 5 to 15). Other 
domains commonly occurring in concert with 
LRR domains in neuronal LRR membrane 
proteins are immunoglobulin (IgG) -like 
domain and fibronectin (Fn) type III repeat: 
IgG-like domain is present in 20 and Fn type 
III repeat in 13 out of these 41 proteins. The 
order of domains in the polypeptide chain is 
defined: if other domains than LRR-domain 
are present, then IgG-like domain(s) lie 
carboxyl-terminal to the LRR-domain, and 
Fn type III repeat lies carboxyl-terminal to 
the IgG-like domain(s). The role of IgG-like 
domains and Fn type III repeat domains 
occurring in these proteins has not been 
studied extensively. In the case of NGL-1, 
the IgG-like domain was found not to have a 
role in Netrin-G1 binding (Lin et al. 2003). In 
LINGO-1 the IgG-like domain was noted to 
cause a sharp ~90º angle between the LRR 
and IgG-like domains, and thereby placing 
the IgG-like domain in close apposition with 
the convex side of the LRR domain (Mosyak 
et al. 2006). This induced turn in the LINGO-
1 polypeptide chain orientation could be 
critical for presenting the associated LRR 
domain in a correct orientation in relation to 
the plasma membrane.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Genes encoding neuronal LRR membrane proteins described in the literature. LRRTM, leucine-rich 
repeat transmembrane neuronal; SLITRK, Slit and Trk-like; Amigo, amphoterin-induced gene and ORF; Alivin-1, 
activity-dependent leucine-rich repeat and Ig superfamily survival-related protein; DEGA, differentially expressed in 
human gastric adenocarcinoma; NGL, netrin-G1 ligand; LRRC, leucine-rich repeat containing; LINGO, LRR and Ig 
domain-containing, nogo receptor-interacting protein; LERN1, leucine-rich repeat neuronal protein 1; LRRN6A, 
leucine-rich repeat neuronal protein 6; FLRT, fibronectin-leucine-rich transmembrane; NLRR, neuronal leucine-rich 
repeat protein; LRIG, leucine-rich repeats and immunoglobulin-like domains protein; LIG-1, leucine-rich repeats and 
immunoglobulin-like domains 1; SALM, synaptic adhesion-like molecule; Lrfn, Leucine-rich repeat and fibronectin type 
III domain-containing; OMgp, oligodendrocyte myelin glycoprotein; NgR, Nogo-66 receptor. S/T, serine/threonine rich 
domain. 
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Protein structure Family name Family members Subcellular 
protein 
localization 
LRRs 
IgG-like 
Fn III 
other 
TM/ GPI 
Intracellular 
Biological function(s) Reference(s) 
LRRTMs 
LRRTM1 
LRRTM2 
LRRTM3 
LRRTM4 
ER, other? 10 - - - 
TM 
yes See Results -chapter 
(I), (Haines and Rigby 
2007) 
SLITRKs 
SLITRK1 
SLITRK2 
SLITRK3 
SLITRK4 
SLITRK5 
SLITRK6 
Trans-golgi 
network, 
plasma 
membrane 
11 - - - 
TM 
yes 
Overexpression in neurons 
affects neurite outgrowth in 
vitro. Rare variants of 
SLITRK1 possibly 
associated with Tourette’s 
syndrome.  
(Aruga and Mikoshiba 
2003; Aruga et al. 2003; 
Abelson et al. 2005) 
Amigos 
AMIGO1 
AMIGO2/ Alivin-1/ 
DEGA  
AMIGO3 
likely plasma 
membrane   6 1 - - 
TM 
yes 
Promote neurite outgrowth 
and fasciculation in vitro; 
Amigo2/alivin-1 inhibits 
neuronal apoptosis in vitro. 
(Kuja-Panula et al. 2003; 
Ono et al. 2003; Rabenau 
et al. 2004) 
NGLs 
NGL-1 
NGL-2/LRRC4 
NGL-3 
plasma 
membrane 9 1 - - 
TM 
yes 
NGL-1 binds to Netrin G1 
and attracts thalamic 
neurons. NGLs promote 
synapse formation. 
(Lin et al. 2003; Zhang et 
al. 2005; Kim et al. 2006) 
LINGOs 
LINGO-1/ LERN1/ 
LRRN6A 
LINGO-2 
LINGO-3 
plasma 
membrane   12 1 - - 
TM 
yes 
Negative regulator of 
myelination in vivo. Role in 
regeneration in vivo. Co-
receptor for NgR1.  
(Carim-Todd et al. 2003; 
Mi et al. 2004; Mi et al. 
2005; Ji et al. 2006; Lee 
et al. 2007) 
FLRTs 
FLRT-1 
FLRT-2 
FLRT-3 
plasma 
membrane   10 - 1 - 
TM 
yes 
Overexpression of FLRT-3 
promotes neurite outgrowth 
in vitro. Xenopus Laevis 
FLRT-3 interacts with 
FGFRs. FLRTs interact 
homophilically 
(Lacy et al. 1999; 
Bottcher et al. 2004; 
Robinson et al. 2004; 
Tsuji et al. 2004; 
Karaulanov et al. 2006) 
NLRRs 
NLRR-1 
NLRR-2/GAC1 
NLRR-3 
NLRR-5 
plasma 
membrane  12 1 1 - 
TM 
yes 
NLRR-3 facilitates EGF 
internalization and 
signaling.  
(Taguchi et al. 1996; 
Fukamachi et al. 2002; 
Hamano et al. 2004) 
 
 NLRR-4  n.d. 11 - 1 - 
TM 
yes 
Not parologous to NLRR1-
3. NLRR-4 knock out mice 
have memory deficits. 
(Bando et al. 2005) 
LRIGs 
LRIG-1/  
LIG-1 
LRIG-2 
plasma 
membrane 15 3 - - 
TM 
yes 
LRIG-1 is expressed 
predominantly in glial cells. 
LRIG-1 enhances 
ubiquitylation and 
degradation of EGFR in 
vitro. LRIG-1 null mice 
develop skin disorder 
reminiscent of psoriasis.  
(Suzuki et al. 1996; 
Suzuki et al. 2002; 
Nilsson et al. 2003; Gur et 
al. 2004; Laederich et al. 
2004) 
SALMs 
SALM1 
SALM2 
SALM3 
SALM4 
SALM5 
(also called as 
Lrfns) 
plasma 
membrane 6 1 1 - 
TM 
yes 
Regulate multiple aspects 
of neuronal differentiation, 
including neurite outgrowth, 
spine formation, and 
assembly of excitatory 
synapse apparatus.  
(Ko et al. 2006; Wang et 
al. 2006) (Morimura et al. 
2006) 
 Lib/LRRC15 plasma membrane 15 - - - 
TM 
yes 
Expression induced by β-
amyloid in rat astrocytes in 
vitro. 
(Satoh et al. 2002; Satoh 
et al. 2005) 
 Pal 
ER, secretory 
pathway; not 
on the plasma 
membrane 
5 1 1 - 
TM 
yes Retina-specific expression. (Gomi et al. 2000) 
 Nyctalopin plasma membrane 11 - - - 
GPI - 
Expressed in the retina, 
brain and in some other 
organs. Mutated in X-linked 
complete congenital 
stationary night blindness  
(Bech-Hansen et al. 
2000; Pusch et al. 2000; 
Pesch et al. 2003; Zeitz et 
al. 2003) 
 OMgp plasma membrane 8 - - 
S/T 
GPI - 
Binds Ngr1 and MAG. 
Inhibits neurite outgrowth in 
vitro and in vivo. 
(Wang et al. 2002; 
Vourc'h and Andres 2004; 
Huang et al. 2005) 
NgRs 
NgR1 
NgR2 
NgR3 
plasma 
membrane 8 - - - 
GPI - 
NgR1 and likely NgR2 
mediate ‘myelin inhibition of 
neurite growth’ 
(II), (Barton et al. 2003; 
Pignot et al. 2003)  
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Only OMgp (oligodendrocyte myelin 
glycoprotein) contains some additional 
extracellular elements not discussed above: it 
contains a unique serine-threonine rich region 
between the LRR domain and GPI-anchor 
modification site. It is unclear whether this 
segment folds and forms a globular protein 
domain structure or it provides a less ordered 
linker sequence between the LRR domain and 
the TM segment.  
 
OMgp, NgR family members (3 genes) and 
nyctalopin are GPI-anchored proteins. Other 
neuronal LRR membrane proteins contain a 
relatively small (~50-100 amino acid long) 
intracellular part following the TM segment. 
None of these 36 neuronal type I 
transmembrane LRR proteins contains an 
intracellular part with enzymatic activity, and 
the possible downstream signaling events 
triggered by these proteins are unclear at the 
molecular level. Several type I transmembrane 
LRR proteins contain a carboxyl-terminal 
sequence that could serve as a binding site for 
PDZ-proteins (named after three first identified 
proteins with PDZ-domain: PSD-95, Discs-
large, and ZO-1). PDZ-domain containing 
proteins are involved in diverse physiological 
processes. Importantly many of them serve 
scaffolding functions in synapses (Hung and 
Sheng 2002; Kim and Sheng 2004). SALM1, 
SALM2, and NGL-2 associate with PSD-95, as 
well as with other PDZ-domain containing 
proteins present in the synapse (Kim et al. 
2006; Ko et al. 2006; Wang et al. 2006).  
1.5.2 Emerging common themes in 
neuronal LRR membrane protein biology 
 
In vitro experiments have established that 
most neuronal LRR membrane proteins are 
transported to the plasma membrane. Notably, 
Pal is known to localize predominantly along 
the secretory pathway (Gomi et al. 2000), and 
my observations suggest the same for 
LRRTM1 (IV). Subcellular localization of 
neuronal LRR membrane proteins has been 
typically assessed by overexpresssing the 
gene-of-interest in cell lines. No studies 
addressing subcellular localization of any 
endogenous neuronal LRR membrane protein 
using well characterized antibody 
(demonstrated by showing lack of signal in 
knock out tissue sections) have been 
performed. Even by using less stringently 
characterized antibodies, only NgR1 has been 
shown to be localized at least partially to the 
plasma membrane (Wang et al. 2002). The 
PDZ-domain binding motif, which is present in 
several members of the neuronal LRR 
membrane protein family, seems to play an 
essential role in regulating their protein-
protein-interactions at least in some cases, 
and could thus control their intracellular 
localization as well (Kim et al. 2006; Wang et 
al. 2006).  
 
Several neuronal LRR membrane proteins 
have been suggested to be involved in 
regulating neurite outgrowth (at least Slitrks, 
Amigos, FLRTs, SALMs, NgR1, NgR2, OMgp, 
NGL-1; references in Table 2) either when 
overexpressed in neurons or presented as a 
soluble or surface-bound exogenous proteins. 
This is consistent with the LRR domain’s role 
in protein-protein–interactions; it could 
therefore affect the adhesion of neurons to 
substrates. Alternatively, intracellularly 
localized pools of proteins could regulate the 
transport of other proteins needed for neurite 
outgrowth. However, it should be noted that 
experiments measuring neurite outgrowth are 
likely to be among the first in vitro experiments 
to be performed with a neuronally expressed 
gene of unknown function, and therefore 
observed effects are likely not representative 
of a full spectrum of functions that neuronal 
LRR membrane proteins serve. Furthermore, 
out of the proteins mentioned above, in vivo 
physiological role in regulating neurite growth 
has been established only for OMgp (Huang et 
al. 2005). Evidence suggesting in vivo 
physiological role in axonal growth and 
guidance is relatively strong also for NGL-1  
(Lin et al. 2003). Several lines of evidence 
associates NgR1 with the regulation of neurite 
outgrowth in pathological settings (for review, 
see (Yiu and He 2006)). Other emerging 
functions for neuronal LRR membrane 
proteins are regulation of growth factor 
signaling (NLRR-3 and LRIG-1; Table 2), and 
synapse formation/function (SALMs).  
 
In summary several neuronal LRR membrane 
proteins have important roles in regulating 
euronal form and function. Neuronal LRR 
membrane proteins can serve as ligands (e.g. 
NGL-1), as receptors (e.g. NgR1), or as both 
(e.g. OMgp). Most members of the neuronal 
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LRR membrane protein family seem to 
function in a non-cell-autonomous manner, but 
their intracellular localization and other 
evidence suggest that some members (Pal, 
LRRTM1, SALMs, Slitrks) are likely to have 
important cell-autonomous functions. 
1.5.3 Example of neuronal LRR membrane 
proteins: NGL family 
 
NGL-1 was identified as a high-affinity ligand 
for netrin-G1 (Lin et al. 2003) from an 
expression cloning screen. NGL-1 belongs to 
a three member NGL family; all family 
members contain nine LRRs, an IgG-like 
domain, transmembrane segment, and a short 
intracellular region, which ends carboxyl-
terminally with a likely PDZ-domain binding 
sequence (E-T-Q-I). Surface-bound NGL-1 
promotes outgrowth of embryonic thalamic 
axons in vitro whereas soluble NGL-1 inhibits 
outgrowth when injected into neural tube of 
early chick embryos. Netrin-G1 is highly 
expressed in mouse thalamic neurons, 
whereas NGL-1 is expressed in striatum and 
cerebral cortex – intermediate and final targets 
for thalamocortical axons, respectively. All this 
data suggests that NGL-1 is likely to play a 
role in axon guidance: NGL-1 is likely a 
surface-bound short range chemoattractant 
ligand that signals in netrin-G1 dependent 
manner to promote growth of thalamocortical 
axons (Lin et al. 2003). However, in vivo loss-
of-function experiments to confirm this remain 
to be completed.    
 
A recent study has shed light on the possible 
functions of NGL-2 in adulthood, suggesting 
that NGL-2 is a regulator of neuronal 
morphology and also a postsynaptic 
membrane protein that instructs the formation 
of excitatory synapses. (Kim et al. 2006). 
Specifically, NGL-2 was found to promote 
formation of dendritic protrusions when 
overexpressed, interact with PSD-95, and 
induce presynaptic differentiation in a non-cell-
autonomous manner (when presented on the 
surface of HEK293 cells or on microbeads). 
Furthermore, NGL-2 knockdown reduced the 
number of excitatory synapses in cultured 
hippocampal neurons. The functions of NGL-2, 
might be at least partially mediated by netrin-
G2, as the authors found that these two 
proteins interact physically (Kim et al. 2006).  
 
Both NGL-1 and NGL-2 are prominently 
expressed in the adult human brain (Lin et al. 
2003; Zhang et al. 2005); their possible roles 
in synaptic plasticity remain to be studied. 
1.5.4 Example of neuronal LRR membrane 
proteins: SALM family 
 
SALMs (synaptic adhesion-like molecules) 
compose a recently characterized five member 
subfamily of neuronal LRR membrane 
proteins. Their extracellular region contains six 
LRRs, an IgG-like domain, and a fibronectin 
type III domain. All SALMs possess a short 
intracellular region, and in SALMs 1-3 it ends 
carboxyl-terminally with a consensus PDZ-
domain binding sequence. SALM1 and SALM2 
were identified by yeast-two hybrid screening 
as proteins that bind to PDZ-domains of 
SAP97 and PSD-95 (Ko et al. 2006; Wang et 
al. 2006), respectively. SALM2 was also 
shown to interact with other synaptic PDZ-
proteins (SAP97, Chapsyn-110, SAP102), and 
SALM1 was found to bind to PSD-95 as well. 
These interactions, as well as the plasma 
membrane targeting of SALM1, is dependent 
on the C-terminal PDZ-domain binding 
sequence.  
 
Interestingly, SALMs seem to regulate multiple 
aspects of neuronal differentiation. 
Overexpression of SALM1 increases neurite 
outgrowth twofold (Wang et al. 2006) in young 
hippocampal (4 DIV) neurons, but not in older 
(14 DIV) ones (Wang et al. 2006). SALM1 can 
also interact and cluster NMDA receptors 
(Wang et al. 2006). On the other hand SALM2 
was found to localize to excitatory, but not to 
inhibitory synaptic sites, and there it interacts 
with AMPA receptors to some degree, but 
more strongly with PSD-95 (Ko et al. 2006). 
Overexpression of SALMs seems to have 
various effects on spine formation, but more 
studies are required to resolve the partially 
conflicting effects observed (Ko et al. 2006; 
Wang et al. 2006). In vivo studies are 
necessary to confirm the reported roles of 
SALMs in regulating neurite morphology and 
function. In contrast to NGLs, SALMs do not 
induce the formation of presynaptic 
specializations in cells. Thus SALMs may 
function cell-autonomously whereas NGLs can 
function a non-cell-autonomously as well.  
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1.5.5 Example of neuronal LRR membrane 
proteins: Slitrk family 
 
The Slitrk-family has six members, with each 
containing 11 LRRs, broken into two 
segments, in their extracellular (or in ER/Golgi 
lumen) region. Additionally, they have a TM 
segment and a short intracellular region 
(Aruga and Mikoshiba 2003). Their name Slitrk 
refers to their similarity to Slit and Trk family 
members, although the LRRs of Slitrks are no 
closer to those of Slit than to any other LRR 
protein, and the resemblance of Trks is limited 
to a presence of 0-4 tyrosine residues in the 
assumed intracellular region in different Slitrk 
family members. No evidence indicates that 
these tyrosines are being phosphorylated. All 
Slitrk family members are prominently 
expressed in the brain and spinal cord (Aruga 
and Mikoshiba 2003). Different Slitrk family 
members seem to have opposing effects on 
neurite outgrowth: In PC12 and Neuro-2a 
neuroblastoma cells as well as in cortical 
neuron cultures, overexpression of Slitrk1 
promotes neurite outgrowth, whereas in same 
neuronal cell lines overexpressed Slitrk2 
restricts neurite outgrowth (Aruga and 
Mikoshiba 2003; Abelson et al. 2005).  
 
Sequence variants in Slitrk1 have been 
suggested to be associated with Tourette’s 
syndrome (Abelson et al. 2005). The study by 
Abelson et al. was inspired by the finding of a 
chromosomal inversion in the vicinity of Slitrk1 
locus. However, this inversion did not overlap 
with the Slitrk1 gene. Detailed sequencing of 
174 individuals affected with Tourette’s 
syndrome revealed one non-sense mutation in 
the ORF, and one variant in two unrelated 
affected individuals in the 3’ UTR (‘var321’) 
that where not found in 3600 and 4296 control 
chromosomes, respectively. However, recent 
studies have failed to confirm these 
observations: the ‘var321’ was also found in 
non-affected Caucasian individuals (Wendland 
et al. 2006) and in several non-affected 
Ashkenazi Jews (Keen-Kim et al. 2006). 
Another study did not identify associated ORF 
variants or ‘var 321’ in 82 Tourette’s syndrome 
patients (Deng et al. 2006). These results 
suggest that the putative Slitrk1 association 
with Tourette’s syndrome is unlikely to be 
beneficial in clinical diagnostics, and highlight 
the importance of using precisely matched 
case and control populations in association 
analyses of rare variants. 
1.5.6 Example of neuronal LRR membrane 
proteins: AMIGO family 
 
AMIGO1 was discovered using differential 
display -method as a transcript upregulated in 
neurons by neuronal growth-promoting factor 
amphoterin (Kuja-Panula et al. 2003). 
AMIGO2 and AMIGO3 were successively 
identified by bioinformatics. All three AMIGOs 
share similar domain architecture: they 
possess six LRRs and one IgG-like domain 
extracellularly (or in ER/Golgi lumen), followed 
by a TM segment and a short intracellular 
region. AMIGO1 mRNA is brain-enriched 
whereas the two other AMIGOs are more 
widely expressed in the adult mouse (Kuja-
Panula et al. 2003). AMIGO1 protein is 
particularly abundant in the fiber tracts in brain 
and in the neurites of cultured hippocampal 
neurons.  
 
Interestingly, substrate coated with AMIGO1-
Fc recombinant protein promotes hippocampal 
neurite outgrowth, and this effect can be 
reversed by soluble AMIGO1 ectodomain. 
Soluble AMIGO1-Fc protein also inhibits 
fasciculation of hippocampal neurites in vitro. 
As fasciculation involves homophilic 
interactions, Kuja-Panula et al. hypothesized 
that AMIGOs might show homophilic 
adhesion. Consistent with this hypothesis, all 
AMIGOs were found to co-immunoprecipitate 
with each other, and also to promote 
homophilic adhesion in bead aggregation 
assays. In the future studies, it would be 
worthwhile to quantify the binding affinities; the 
question of plasma membrane localization of 
AMIGOs should be addressed as well. In 
cultured neurons AMIGO2 expression is 
activity-dependent, and it inhibits apoptosis 
(Ono et al. 2003). Finally, AMIGO2 has also 
been suggested to have a role in the etiology 
of gastric adenocarcinoma (Rabenau et al. 
2004). These potentially important findings 
warrant further studies to establish the main in 
vivo functions of AMIGO family members. 
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1.6 Nogo-A and Nogo-66 Receptor in 
axonal regeneration  
 
This thesis addresses in part questions 
concerning the Nogo-66 Receptor 
(NgR/NgR1). Therefore, the earlier studies of 
this particular neuronal LRR membrane 
protein are discussed here in more detail. A 
number of studies have suggested that NgR1 
mediates oligodendrocyte/myelin-to-neuron 
signals that inhibit CNS axon regeneration 
(reviewed in (McGee and Strittmatter 2003; 
Yiu and He 2006)). 
1.6.1 Myelin inhibitors of neurite growth  
 
Here I use the term ‘myelin inhibition of neurite 
growth’ to refer to the phenomenon that CNS 
myelin proteins inhibit axonal growth and 
regeneration, both in vitro and in vivo. CNS 
axons regenerate minimally after injury, but 
they exhibit robust growth into peripheral 
nerves grafted into rat CNS (David and 
Aguayo 1981). A similar pattern  was also 
observed by Dr. Martin Schwab and Dr. Hans 
Thoenen in in vitro assays: the growth of rat 
dorsal root ganglion (DRG), sympathetic or 
retinal neurons is limited when grown on rat 
optic nerve explants (containing CNS myelin) 
as compared to when grown on sciatic nerve 
explant (containing PNS myelin) (Schwab and 
Thoenen 1985). This inhibitory activity was 
shown to be enriched in the white matter 
fraction of CNS (Savio and Schwab 1989). 
Furthermore, co-culture studies revealed that 
growing neurites avoid making contacts with 
mature oligodendrocytes (Schwab and Caroni 
1988).  
 
The observation that direct contact between 
the growing neurite and oligodendrocyte is 
needed for the growth inhibition suggested 
that the growth inhibition was mediated by 
ligand-receptor interaction (Schwab et al. 
1993). Since the discovery of Nogo-A as the 
first myelin-derived inhibitor of neurite growth 
(below) the research on myelin inhibition of 
neurite growth has expanded rapidly. This 
expansion was facilitated by the identification 
of several other CNS myelin-derived molecular 
species that limit axonal growth. These include 
myelin-associated Nogo-A, MAG (myelin-
associated glygoprotein), OMgp 
(oligodendrocyte myelin glycoprotein) and 
astroglial scar-derived chondroitin sulfate 
proteoglycans (CSPGs), and EphA4 (reviewed 
in (Yiu and He 2006)). 
1.6.2 Identification of Nogo-A  
 
In 1988 Caroni and Schwab identified two 
membrane proteins from SDS-PAGE 
fractionated CNS myelin that potently inhibited 
neurite outgrowth and 3T3 fibroblast 
spreading. These species were named as NI-
35 and NI-250 after their apparent molecular 
weight (in kDa) in SDS-PAGE (Caroni and 
Schwab 1988). Caroni and Schwab also 
demonstrated that IN-1 and IN-2 monoclonal 
antibodies raised against these species could 
neutralize the inhibitory activity of CNS myelin 
on neurite growth and on 3T3 fibroblast 
spreading (Caroni and Schwab 1988). The IN-
1 antibody (raised against NI-250 fraction) was 
also noted to cross-react with NI-35 fraction, 
suggesting that these two species share 
molecular similarities. IN-1 antibody also 
recognized an unidentified 50 kDa protein from 
CNS myelin. The molecular properties and 
partial amino acid sequence of NI-250 (named 
as bNI-220 as isolated from bovine brain and 
had an apparent molecular weight of 220 kDa) 
protein were described much later as its 
enrichment and purification to homogeneity 
required complicated methodology (Spillmann 
et al. 1998). Based on one of the amino acid 
sequence reads obtained, Spillmann et al. 
suggested that bNI-220 might be a member of 
the reticulon (RTN) family of proteins.  
 
Soon after the study by Spillmann et al. three 
groups independently identified the gene 
encoding bNI-220 as Reticulon-4 (Rtn4), 
renamed the active splice variant as Nogo-A, 
and demonstrated that Nogo-A is expressed 
on the surface of oligodendrocytes (Chen et al. 
2000; GrandPre et al. 2000; Prinjha et al. 
2000). Rat Nogo-A is composed of 1163 
amino acids, but it migrates on SDS-PAGE as 
a ~200 kDa protein. It contains carboxy-
terminal ~200 amino acid reticulon homology 
domain (RHD), which is present in all Rtn 
family members. The RHD consists of two 
hydrophobic segments flanking a 66 amino 
acid long hydrophilic sequence. The long 
(~1000 amino acid) amino-terminus of Nogo-A 
shares no homology with other proteins. Nogo-
A does not have a signal peptide and the 
mechanism responsible for its integration to 
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plasma membrane remains elusive. Based on 
in vitro neurite outgrowth assays utilizing 
purified fragments of Nogo-A, GrandPre et al. 
argued that neurite outgrowth activity of Nogo-
A is mediated by 66 amino acid loop region 
(Nogo-66 segment) within the RHD, which is 
present in all Nogo splice variant (Nogo-A, -B, 
and -C), whereas Prinhja et al. showed that 
the amino-terminal region unique for Nogo-A 
inhibits neurite outgrowth.  
1.6.3 Nogo-66 receptor (NgR1) and its 
ligands 
 
Using expression cloning methodology 
GrandPre et al. identified Nogo-66 Receptor 
(NgR/NgR1) as a receptor mediating neurite 
outgrowth inhibitory activity of the Nogo-66 
segment (GrandPre et al. 2000). The neuronal 
receptor for the N-terminal segment of Nogo-A 
is still unknown. NgR1 is a 
glycosylphosphatidylinositol (GPI) -anchored 
membrane protein that contains extracellularly 
eight LRRs flanked by cysteine-rich capping 
modules. Its crystal structure has been 
determined (Figure 1), and as predicted, it 
forms a structure typical for LRR superfamily 
members (Barton et al. 2003; He et al. 2003). 
NgR1 is widely expressed in the CNS.  
 
Soon after the identification of NgR1 as a 
receptor for Nogo-66, two groups 
independently reported that MAG (myelin 
associated glycoprotein), another inhibitory 
component of CNS myelin, binds to and 
signals via NgR1 (Domeniconi et al. 2002; Liu 
et al. 2002). The neurite-outgrowth inhibitory 
activity of MAG had been described much 
earlier (McKerracher et al. 1994; 
Mukhopadhyay et al. 1994). Surprisingly, a 
third inhibitory protein in the CNS myelin, 
OMgp (oligodendrocyte myelin glycoprotein), 
was also suggested to use NgR1 for binding 
and signaling (Wang et al. 2002). At the same 
time the neurite-outgrowth inhibiting activity of 
OMgp was described independently by 
another group as well (Kottis et al. 2002). 
Summary of these interactions is provided in 
Figure 2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Proteins involved in NgR1 signaling 
pathways as known in June, 2002. This diagram 
represents the state of knowledge before a study by 
Venkatesh et al. (Venkatesh et al. 2005) and a part of 
this thesis work (III) was published. Three myelin-
associated ligands Nogo-A, OMgp, and MAG all bind to 
neuronal NgR1 with low nanomolar dissociation 
constants. See Figure 7 for an up-to-date model. The 
schematic drawing is not in scale. 
 
 
 
As NgR1 is a GPI-anchored protein, it seems 
logical that it needs a co-receptor to conduct 
signals to the intracellular space. Recent years 
have provided evidence for several co-
receptors. Initially it was noted, that p75, 
originally characterized as neurotrophin 
receptor, could mediate NgR1-signalling, and 
form a complex with NgR1 (Wang et al. 2002; 
Wong et al. 2002). However, the very limited 
expression of p75 in the adult CNS raised a 
question whether p75 is a bona fide co-
receptor. Later, a structurally related TNFR 
superfamily member TROY/Taj was shown to 
also function as a co-receptor (Park et al. 
2005; Shao et al. 2005). Additionally, a third 
and necessary component of the receptor 
complex was identified as LINGO-1, another 
member of neuronal LRR membrane protein 
family (Mi et al. 2004). Reported in vivo 
evidence supports the role of all of these three 
above mentioned co-receptors in mediating 
myelin inhibition of neurite growth, but their 
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relative importance remains unclear (for 
review, see (Yiu and He 2006)).  
 
Intracellular signaling pathways engaged in 
NgR1 signaling are largely unclear but they 
seem to share similarities with signaling 
mechanisms used by other repulsive guidance 
cues. The key downstream signaling pathway 
might be RhoA small GTPase and its 
downstream target ROCK/ROCK2 (Rho-A 
associated kinase), which regulates actin 
cytoskeleton stability at the growth cone. 
However, also other signaling pathways 
(protein kinase C, EGF receptor, calcium ions 
are also implicated in NgR1 signaling (for 
review, see (Yiu and He 2006)). 
1.6.4 Therapeutic potential of perturbing 
Nogo-A and NgR1 function 
 
Reviewing in detail the extensive literature 
addressing the in vivo role of myelin inhibitors 
of neurite growth is beyond the scope of this 
thesis work. Briefly, Nogo-A monoclonal 
antibodies (Schnell and Schwab 1990; 
Bregman et al. 1995; Wiessner et al. 2003), 
NgR1 function-blocking peptide (NEP1-40) 
(GrandPre et al. 2002; Li and Strittmatter 
2003), and NgR1 function-blocking 
recombinant protein (soluble NgR1 
ectodomain) (Lee et al. 2004; Li et al. 2004; 
Wang et al. 2006) all enhanced axonal 
regeneration and functional recovery after 
spinal cord injury or stroke in rodents.  
 
The genetic data regarding the role of Nogo-A 
in spinal cord regeneration, obtained by 
analyzing independently made mouse knock 
out lines, is controversial (Kim et al. 2003; 
Simonen et al. 2003; Zheng et al. 2003; 
Cafferty and Strittmatter 2006). Similarly, Kim 
et al. and Zheng et al. obtained very different 
results when analyzing regenerative abilities of 
independently prepared NgR1 knock out 
mouse lines (Kim et al. 2004; Zheng et al. 
2005). Reconciliation of disparities is further 
complicated by the inherent differences in the 
regenerative ability of commonly used mouse 
strains (Dimou et al. 2006), and by the 
complex genetic background of most of the 
mice used in the above mentioned genetic 
studies. 
 
Of these Nogo-A and NgR1 inhibitors, 
monoclonal antibodies against Nogo-A 
represent the most advanced project with the 
goal of treating human patients with spinal 
cord injury. Nogo-A antibodies have provided 
promising results in monkey spinal cord injury 
experiments (Freund et al. 2006). Fully 
humanized Nogo-A antibody is in clinical trials 
for acute spinal cord injury, and the phase I 
safety trial has been largely completed with 
favorable safety profile (Dr. Martin Schwab, 
personal communication).  
  
 
1.7 Genetic basis of left-right brain 
asymmetry  
 
We found that a certain LRRTM1 haplotype is 
associated with handedness, and also to 
schizophrenia in Caucasian populations. 
Therefore I provide here an overview on brain 
asymmetry, handedness, and schizophrenia. 
 
Overall, the left and right brain hemispheres 
function differently during human cognition, 
behavior, and emotion. Handedness is a 
prominent example of functional hemispheric 
differences. Whereas dorso-ventral (D-V) and 
anterior-posterior (A-P) axis formation in the 
spinal cord and CNS has been studied 
intensively, few studies have illuminated the 
molecular basis of distinctions between the left 
and right hemispheres (Sun et al. 2005; 
Moskal et al. 2006; Sun et al. 2006). 
 
Ninety percent of humans are more skilled at 
motor tasks with their right hand (i.e. left 
hemisphere-dominant). While approximately 
95% of right-handed and 70% of left-handed 
people process language predominantly in the 
left hemisphere, spatial recognition is more 
dependent on the right hemisphere. At the 
anatomical level, differences between the 
hemispheres are most prominent in the 
frontotemporal regions, specifically along the 
Sylvian fissure (typically longer in the left 
hemisphere), and in the planum temporale 
(typically larger on the left side) (reviewed in 
(Sun and Walsh 2006)). Handedness is the 
most easily measured aspect of human brain 
asymmetry, and relative handedness can be 
quantified using tasks that require fine-motor 
skills. Studies of handedness may provide 
insight into the general mechanisms of brain 
asymmetry. 
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In the case of D-V and A-P axis formation in 
the CNS, symmetry is broken by asymmetric 
morphogen expression from a signaling 
center, which triggers graded expression of 
transcription factors that impose positional 
information on cells (Sur and Rubenstein 
2005). Analogously, it is plausible that left-right 
axis formation results from the asymmetric 
expression of certain key signaling 
molecule(s). Studies exploring the molecular 
basis of left-right brain asymmetry have aimed 
to identify asymmetrically expressed genes by 
microarray or SAGE-approaches. The most 
detailed work by Sun et al. (Sun et al. 2005) 
identified 27 genes expressed differentially in 
left and right perisylvian regions of 12-week-
old human brains. Sun et al. also confirmed by 
in situ hybridization that one of the identified 
genes, the transcription factor LMO4, was 
indeed asymmetrically expressed in 
developing human and mouse brain. However, 
as is evident from the high number of genes 
showing asymmetric gene expression in their 
study, microarray analysis seems unlikely to 
identify the “smoking gun” gene(s) that have 
an early causative role in the emergence of 
left-right brain asymmetry. Therefore studies 
on the genetics of human handedness offer a 
unique possibility to gain insight into this 
fundamental property of human brain. 
1.7.1 Co-evolution of handedness and brain 
asymmetry 
 
Although even drosophila (Pascual et al. 2004) 
and zebrafish (Lin and Burdine 2005) show 
well documented asymmetries in the anatomy 
and physiology of their CNS, there is no 
evidence to suggest that handedness, defined 
as a superior dexterity of either forelimb, would 
have emerged as a hereditary trait in other 
species than in humans and possibly in great 
apes. Generally the emergence of at least 
partially bipedal posture has been suggested 
to be necessary for enabling the use of 
manual gestures and handedness to emerge 
(Gentilucci and Corballis 2006).   
 
Population-level handedness (better fine-
motor skills) emerged very recently in 
evolution: the evidence for population-level 
handedness is limited even for apes not grown 
up in captivity (Sun and Walsh 2006). Mus 
musculus do not show population-level 
handedness, although individual mice do show 
consistent forelimb preference in pellet-
reaching tasks (Betancur et al. 1991; Biddle et 
al. 1993). The strength of paw-preference 
lateralization is, however, genetically 
controlled: some inbred mouse strains show 
weakly whereas others (e.g. C57Bl/6 (Collins 
1975)) show strongly lateralized paw 
preference. Unlike in humans, in mice the 
preference for left or right paw usage seems to 
arise as an outcome of a random process 
(Collins 1975).  
 
It has been proposed that handedness and 
language co-emerged in evolution – that 
language evolved from manual gestures, 
gradually incorporating vocal elements 
(Corballis 2003). This theory suggests that 
hemispheric specialization for language may 
be predated by and may have evolved from 
hemispheric specializations for manual 
gestures used in communication. Importantly, 
humans show strong population-level bias for 
both right handedness (i.e. dominant left 
hemisphere) and also for the lateralization of 
language processing (predominantly in the left 
hemisphere) and the lateralization of 
handedness and language processing are 
tightly correlated: 99% of right-handed people 
process language in the left hemisphere. This 
strong correlation, and the use of hand signals 
to accompany speaking, has been interpreted 
to suggest their co-evolution. Furthermore, 
although great apes use vocalization for 
signaling, attempts to teach them to use 
language have been more successful when 
using manual signs (Gentilucci and Corballis 
2006). 
 
Genes involved in human handedness are 
likely to have an effect on the development of 
human brain left-right asymmetry. Brain 
asymmetry is fundamental not only to 
language, as detailed above, but to much of 
human thought and emotion (Sun and Walsh 
2006). Studies on genes involved in brain 
asymmetry may thus yield novel insights into 
the biological basis of human cognition. 
1.7.2 Genes and genomic regions 
implicated in handedness 
 
Handedness is a partially hereditary trait 
(Francks et al. 2002). Studies of the genetics 
of human handedness were pioneered by Dr. 
Francks and colleagues: they performed the 
first genome-wide linkage screen for a 
quantitative measure of human handedness, 
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and found linkage to 2p12-q11 (Francks et al. 
2002). Later the 2p12-q11 linkage was 
replicated in a different sample (Francks et al. 
2003). They also demonstrated that this 
linkage was derived entirely from paternal 
inheritance of the 2p12-q11 region (Francks et 
al. 2003). This observation suggested that the 
underlying gene was imprinted, and 
inactivated or down-regulated on the 
maternally inherited chromosome. In a meta-
analysis of 20 linkage screens for 
schizophrenia, 2p12-q22 was the only location 
to reach overall statistical significance (Lewis 
et al. 2003).  
 
Previously Francks et al. demonstrated that 
the 2p12-q11 linkage to schizophrenia was 
also due to a paternally inherited risk allele 
(Francks et al. 2003). As parent-of-origin 
effects are unusual in the genome (currently 
about 50 imprinted genes are known (Morison 
et al. 2005)). Francks et al. proposed in 2003 
that a single paternally expressed gene was 
responsible for the linkages of 2p12-q11 to 
handedness and schizophrenia (Francks et al. 
2003). 
 
 
1.8 Schizophrenia 
 
The prevalence of schizophrenia is ~1%, and 
therefore it is a major health and social 
problem (Freedman 2003). The patient’s 
response to current therapies is typically only 
partial. One of the main factors limiting the 
development of new drugs is the lack of useful 
animal models (Gogos and Gerber 2006; 
Powell and Miyakawa 2006). Recent advances 
in schizophrenia genetics have activated the 
field studying the etiology of schizophrenia. 
The current paradigm in schizophrenia 
research regards the defects in  CNS 
development and plasticity as the likely 
etiology (Gogos and Gerber 2006). According 
to this paradigm, schizophrenia might be an 
end-result of a developmental defect, possibly 
of embryonic origin.  
1.8.1 Schizophrenia genetics 
 
Like handedness and brain asymmetry, 
schizophrenia is likely to be an etiologically 
complex trait with several, or many, genetic 
and environmental influences. Schizophrenia 
has an even stronger genetic component than 
handedness: first-degree relatives of a 
schizophrenic patient have ten-fold risk of 
developing the disease. Although each 
susceptibility gene allele increases the 
probability of schizophrenia only moderately, a 
combination of genetic risk factors can largely 
increase the likelihood of developing the 
disease.  
 
Significant advances have been made in 
schizophrenia genetics in recent years. 
Currently, there is evidence associating 
variation in at least 13 genes to schizophrenia. 
Particularly certain SNPs and haplotypes in 
dysbindin and neuregulin-1 genes have been 
reported to be associated with increased risk 
of schizophrenia in ten and at least in nine 
independent studies, respectively. On the 
other hand, in several studies these 
associations were not found (for review, see 
(Gogos and Gerber 2006)). 
1.8.2 Schizophrenia and handedness 
 
A recent meta-analysis based on 40 studies 
found that schizophrenia is increased a two-
fold in left- and mixed-handed population 
(Dragovic and Hammond 2005). Several 
studies have also suggested that 
schizophrenia is associated with reductions or 
reversals of normal cerebral asymmetries (see 
e.g. (DeLisi et al. 1997; Chance et al. 2005)). 
Thus, one can gain insight into molecular 
mechanisms underlying both traits by studying 
either of them.  
1.8.3 Animal models in schizophrenia 
research 
 
Over 99% of human genes have a 
corresponding orthologous gene in the mouse 
genome (Waterston et al. 2002). Therefore 
mouse genes orthologous to human 
schizophrenia-associated genes are likely to 
serve in biological roles related to their human 
counterparts’ roles. Using mouse models to 
study the etiology of schizophrenia has many 
advantages over largely observational human 
studies or post mortem analysis of human 
brain samples. Studying animal models 
lacking or overexpressing genes genetically 
linked to schizophrenia could clarify the role of 
these candidate genes in schizophrenia and 
possibly elucidate molecular mechanisms of 
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schizophrenia pathogenesis. However, 
arguably, some schizophrenia symptoms may 
be human-specific (for review in animal 
models in schizophrenia research, see (Powell 
and Miyakawa 2006)). 
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2 AIMS OF THIS STUDY 
 
The general aim of this study was to identify and study novel members of the neuronal leucine-
rich repeat membrane protein superfamily. The specific aims were: 
 
● To perform detailed bioinformatics analyses of identified novel members of the LRR protein 
superfamily (LRRTM and NGR families) [original publications I and II] 
 
● To characterize the mRNA expression pattern of LRRTM and NGR gene family members 
[original publications I, II, and IV] 
 
● To map the intracellular protein localization pattern of LRRTM1, a prototypic LRRTM family 
member [original publication IV] 
 
● To characterize possible ligand-receptor interactions between identified novel NgR family 
members (NgR2 and NR3) and known and candidate NgR1 ligands [original publication III] 
 
● To characterize in detail the interactions between NgR1 and its known ligands [original 
publication III] 
 
● To generate knock out mouse models for the study of the functions of the selected Lrrtm gene 
family members in vivo [previously unpublished; presented here in Results] 
 
● To explore the relevance of LRRTM gene families for human physiology and disease [original 
publication IV] 
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3 MATERIALS AND METHODS 
 
Materials and methods used in this thesis work 
have been described in detail in the original 
articles (see Table 3). Here a short overview 
of the methods used is given; the process of 
generating knock out mice is described in 
more detail.  
 
 
Experimental Procedure Publication 
Bioinformatics I II III IV 
Recombinant DNA technologies I II III IV 
RT-PCR expression analysis I II   
In situ hybridization & neuroanatomical analysis I II III IV 
Cell lines cultures   III IV 
Primary neuronal cell cultures    IV 
Recombinant protein production and affinity 
purification   III  
Immunocytochemistry and light and confocal 
microscopy   III IV 
Cell-based binding assays   III  
Generation of knock out mice See Results 
Human genetics and SNP genotyping     IV 
 
Table 3.  Methods used in this study.  
3.1 Bioinformatics 
 
The main bioinformatics resources used in the 
study are described in Table 4. 
 
3.2 Recombinant DNA techniques 
 
The expression vector constructs used in this 
study are described in Table 5. 
 
3.3 RT-PCR expression analysis 
 
RT-PCR analysis of mRNAs isolated from 
different human and mouse tissues including 
Lrrtm3 knock out brain was done as in (I, II). In 
the Lrrtm3 knock out brain mRNA RT-PCR 
analysis, primers internal for Lrrtm3 exon 2 
were used. 
 
 
 
 
Bioinformatics resource Major use Used in publications Reference 
National Centre for Bioinformatics (NCBI), BLAST tool  
(http://www.ncbi.nlm.nih.gov/blast/) EST identification I II III  (Altschul et al. 1990) 
Univ. California Santa Cruz (UCSC) Genome Browser 
(http://www.genome.ucsc.edu/) 
Analysis of genomic structure of 
genes I II   (Kent et al. 2002) 
Ensembl Genome Browser 
(http://www.ensembl.org) 
Analysis of genomic structure of 
genes I II   (Birney et al. 2006) 
ClustalX and NJPlot program package Multiple sequence alignments; phylogenetics I II   (Chenna et al. 2003) 
SMART (simple modular architecture research tool) tool 
(http://smart.embl-heidelberg.de/) Protein domain identification I II   (Schultz et al. 1998) 
TopPred 
(http://bioweb.pasteur.fr/seqanal/interfaces/toppred.html) 
Topology prediction of membrane 
proteins I II   
(Claros and von Heijne 
1994) 
SignalP 2.0 
(http://www.cbs.dtu.dk/services/SignalP/) 
Signal peptide cleavage site 
prediction I II   (Bendtsen et al. 2004) 
big-PI Predictor 
(http://mendel.imp.ac.at/sat/gpi/gpi_server.html) GPI modification site prediction  II   (Eisenhaber et al. 1999) 
HapMap 
(http://www.hapmap.org/) 
Identification and analysis of 
SNPs     IV (Thorisson et al. 2005) 
InterPro 
(http://www.ebi.ac.uk/interpro/) 
Identification of LRR superfamily 
members This work (Mulder et al. 2007) 
 
 
Table 4. The main bioinformatics resources used in this study. 
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Expression 
construct  
Elements of construct (listed from amino to carboxyl-terminus) Described in 
Myc-LRRTM1 IgK signal peptide, Myc, 6xHis, mouse LRRTM1 cDNA without signal peptide in pSECtag2a IV 
Myc-Lingo-1 IgK signal peptide, Myc, 6xHis, mouse Lingo1 cDNA without signal peptide in pSECtag2a IV 
Myc-MAG IgK signal peptide, Myc, 6xHis, mouse MAG cDNA without signal peptide in pSECtag2a III 
MYC-TLR4 IgK signal peptide, Myc, 6xHis, mouse MAG cDNA without signal peptide in pSECtag2a III 
Myc−NgR Mouse NgR1 (aa 27-473) in pSecTag2-Hygro (Fournier et al. 2001) 
Myc-Ngr2/NGRL3 IgK signal peptide, Myc, 6xHis, mouse NgR2 cDNA without signal peptide in pSECtag2a III 
Myc-Ngr3/NGRL2 IgK signal peptide, Myc, 6xHis, mouse NgR3 cDNA without signal peptide in pSECtag2a III 
FLAG-NgR 
mutants Library of 3xFLAG tagged human NgR mutants in p3xFLAG-CMV™-14 (Sigma) III 
AP-Nogo-66 Rat Nogo66 in pAPtag5 III 
AP-Y4C human Nogo-A, aa 950-1018, in pcAP6 (Hu et al. 2005), III 
AP-Nogo24 human Nogo-A, aa 995-1018, in pcAP6 (Hu et al. 2005), III 
AP-Nogo-C39  Human Nogo-A c-term. 39 aa in pAPtag5 III 
AP-MAG AP-MAG ectodomain fusion (mouse) in pcAP6 (Liu et al. 2002), III 
MAG-AP  MAG ectodomain (mouse) fusion in pAPtag5 III 
AP-OMGP  AP-OMGP ectodomain fusion (mouse) in pAP-5 (Wang et al. 2002), III 
AP-Lingo-1  AP-Lingo ectodomain fusion (human)  (Mi et al. 2004), III 
AP-RTN1-66 66 amino acid RHD loop region of mouse RTN1 in pAPtag5 III 
AP-RTN2-66 66 amino acid RHD loop region of mouse RTN2 in pAPtag5 III 
AP-RTN3-66 66 amino acid RHD loop region of mouse RTN3 in pAPtag5 III 
 
Table 5.  Expression vector constructs used in this study. 
 
3.4 In situ hybridization 
 
Fresh-frozen mouse sections were analyzed 
by in situ hybridization using [α-35S]UTP-
labeled cRNA probes. The probes used are 
described in Table 6. 
 
 
Probe Used in publication 
Mouse LRRTM1, ORF nt 1–448 I   IV 
Mouse LRRTM1, ORF nt 1131–1566 I   IV 
Mouse LRRTM2, ORF nt 1–471 I    
Mouse LRRTM2, ORF nt 1045–1545 I    
Mouse LRRTM3, ORF nt 1–541 I    
Mouse LRRTM3, ORF nt 1061–1542 I    
Mouse LRRTM4, ORF nt 1–431 I    
Mouse LRRTM4, ORF nt 1119–1554 I    
Mouse NgR1, whole ORF  II   
Mouse NgR2/NgRL3, ORF nt 480–1263  II   
Mouse NgR3NgRL2, ORF nt 1-491  II   
Mouse NgR3NgRL2, ORF nt 804-1338  II   
Mouse RTN1, overlaps with RHD  II III  
Mouse RTN2, overlaps with RHD  II III  
Mouse RTN3, overlaps with RHD  II III  
Mouse RTN4, overlaps with RHD  II III  
 
 
Table 6. In situ hybridization probes used in this 
study. RTN1-4 probes contain ORF nucleotides 1778-
2341, 808-1413, 156-711 and 19-597 of GenBank clones 
NM_153457, NM_013648, NM_053076, and 
NM_024226 for RTN1–4, respectively. The probes were 
designed to recognize all splice variants possessing 
RHD. All indicated segments were cloned into pCRII-
TOPO vector (Invitrogen). 
 
3.5 Cell culture 
 
The cell lines (HEK293T, Cos7, Neuro-2a) 
were obtained from ATCC (American Type 
Culture Collection) and grown in DMEM 
(Dulbecco's Modified Eagle's Medium) (Gibco) 
supplemented with 10% FCS (fetal calf serum) 
and antibiotics. 
 
3.6 Neuronal cell culture 
 
Cerebellar granular neurons (CGNs): CGNs 
were isolated from 6-9 days old rats by 
mechanical fragmentation of the isolated 
cerebellum, followed by trypsin and DNaseI 
treatment and Percoll gradient centrifugation. 
CGNs were cultured in Neurobasal-A 
(Invitrogen) supplemented with B27 
(Invitrogen), 5% FCS and 2mM L-glutamine. 
 
Dorsal root ganglia (DRG) neurons: isolated 
dorsal root ganglia from 3-5 weeks old rats 
were digested with collagenase and 
mechanically triturated. DRG neurons were 
cultured in Neurobasal-A supplemented with 
10% FCS, 2 mM L-glutamine and 100 nM 
nerve growth factor (NGF). 
 
Cortical neuron cultures: mouse E17 cerebral 
cortex neurons were isolated by enzymatic 
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(Papin, DispaseII) digestion and mechanical 
trituration of the cerebral cortex. 
 
All neurons were grown on poly-L-lysine and 
laminin coated slides.  
 
Electroporations were performed with Amaxa 
Nucleofector System following the 
manufacturer’s (Amaxa GmbH) instructions. 
 
3.7 Recombinant protein production 
and affinity purification 
 
HEK293T cells were transfected with 
appropriate plasmids encoding secreted AP-
fusion proteins. The conditioned media was 
collected 3-7 days later, sterile-filtered and 
buffered with 20 mM HEPES, pH 7.4. Single-
use aliquots were stored at -20˚C or -70˚C. 
Protein purification was performed with nickel-
nitrilotriacetic acid (Ni-NTA) affinity resin 
according to manufacturer’s guidelines 
(Qiagen). The integrity and amount of AP-
proteins were estimated by PAGE followed by 
Western blotting or Coomassie Blue staining, 
and by pNPP (p-nitrophenyl phosphate) 
alkaline phosphatase (AP) activity assays. 
 
3.8 Immunocytochemistry and light and 
confocal microscopy 
 
Immunocytochemical staining were performed 
using commercially available antibodies as 
described in (III, IV). 
 
3.9 Cell-based ligand binding assays 
 
Cos-7 cells were used in the binding assays 
because they have large surface area and 
they are highly adherent. Routinely 96-well 
plate format was used in binding assays. Cells 
were transfected with Fugene6 (Roche). 48 
hrs after transfection cells were washed with 
Hank’s Balanced Salt Solution (HBSS) and 
subsequently incubated with AP-protein 
conditioned media or purified ligands in HBSS 
+ 0.05% BSA for 3 hrs. The cells were then 
washed extensively with cold HBSS, fixed, and 
then incubated at 67˚C for 14 hrs to inactivate 
endogenous alkaline phosphatase. Finally, the 
bound AP-fusion protein was visualized with 
BCIP/NBP (5-bromo-4-chloro-3-indolyl 
phosphate/nitro blue tetrazolium) it 100 mM 
Tris, pH 9.5. Binding was quantified by 
acquiring multiple images per condition, and 
analyzing the signal intensity with ImageJ 
software (NIH).  
 
3.10 Generation of knock out mice 
 
Mouse Lrrtm1 and Lrrtm3 genes were chosen 
for gene targeting. A single exon encodes the 
whole open reading frame (ORF), or the whole 
ORF minus nucleotides encoding the first 
amino acid in Lrrtm1 and Lrrtm3, respectively. 
This ORF-coding exon was chosen for 
targeting in both cases. 
3.10.1 Targeting constructs 
 
Plasmids backbones used in the construction 
of replacing cassettes were obtained from Dr. 
Peter Mombaerts (Rodriguez et al. 1999). 
They contain the following elements in 5’ -> 3’ 
order: IRES-tauLacZ-loxP-neo-LoxP (used for 
Lrrtm1) and IRES-tauGFP-loxP-neo-LoxP 
(used for Lrrtm3). The targeting constructs 
contained flanking arms varying in length from 
1.2 kb to ~4 kb. 
3.10.2 Embryonic stem cell targeting 
 
Embryonic stem cell (ES cell) targeting was 
performed by electroporating linearized 
constructs into R1 ES cells. After G-418 
selection about 200 colonies were picked per 
targeting event, and analyzed by Southern 
blotting for the presence of homologous 
recombination.  
3.10.3 Mouse breeding schemes 
 
Good percentage chimaeras were used for 
germline transmission. Obtained heterozygous 
mice were mated to generate knock out mice 
and RT-PCR was used to verify the correct 
deletion of mRNA. Lrrtm3 null allele has been 
transferred to C57Bl/6 background (> 9 times 
of backcrossing of heterozygous mice); Lrrtm1 
null allele is similarly being backcrossed to 
C57Bl/6 genetic background.   
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3.10.4 Removal of the neo-cassette 
 
Before backcrossing, heterozygous mice were 
mated with transgenic mice expressing Cre-
recombinase in testes. The correct removal of 
neo-cassette was confirmed by PCR.  
 
3.11 SNP genotyping and human 
genetics 
 
To study genetic variation in LRRTM1 locus in 
humans TaqMan® SNP genotyping assays 
(Applied Biosystems) were used to genotype 
SNPs rs1446109 and rs723524 from 1151 
Han Chinese individuals, belonging to 282 
pedigrees. Real-time PCR reactions were 
performed using ABI 7900 instrument (Applied 
Biosystems); the measured fluorescence 
intensities of the PCR products were used to 
discriminate the alleles. The statistical analysis 
was mainly performed by Dr. Clyde Francks 
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4 RESULTS AND DISCUSSION 
 
4.1 Characterization of LRRTM and 
NGRL gene families 
 
Based on their similarity to LRRs of TrkA, 
several EST clones encoding a gene that was 
later named as LRRTM1 (leucine-rich repeat 
transmembrane neuronal) were identified (I). 
cDNA clones encoding other members of the 
LRRTM family were identified by 
bioinformatics based on their similarity to 
LRRTM1. I found four members of human 
LRRTM gene family, as well as their mouse 
orthologues, Lrrtm1-4. When referring to 
human and mouse genes, capital letters are 
used. 
 
I also discovered two novel members of the 
NGR family in humans and in mouse. These 
NGR family members (NGR2/NGRL3 and 
NGR3/NGRL2) were initially discovered by 
bioinformatics based on their similarity to 
LRRTMs (II). Since NGR2/NGRL3 and 
NGR3/NGRL2 are significantly more closely 
related to each other than to NGR1, and since 
they do not bind Nogo-66, I classify them here 
as members of their own subfamily: ‘NGR like 
(NGRL)-family’. When referring to all three 
genes, I use the name ‘NGR-family’. When 
referring to NGR genes I use capital letters, 
and when referring to proteins, I use 
established format: NgR1, NgR2/(NgRL3) and 
NgR3/(NgRL2). 
4.1.1 The emergence of LRRTM and NGR 
gene families 
 
Orthologous LRRTM and NGR family genes 
can be found in all vertebrates with available 
comprehensive sequence data. No genes 
orthologous to LRRTMs or NGRs are present 
in invertebrate (e.g. Drosophila melanogaster, 
C. elegans) or in Ciona intestinalis -
hemichordate genomic sequence databases. 
 
All LRRs in LRRTMs and in NGR1 and NGR3 
are encoded by a single exon. In NGR2 
(NGRL3) the LRR-encoding region is split into 
two exons.  
 
The commonly intron-free structure of LRR-
encoding segments of genes is also consistent 
with the observation that all LRRs and the 
flanking cysteine-rich capping modules 
commonly create a single functional protein 
domain (see e.g. (III)) therefore likely serving 
as a single modular unit in protein evolution. 
The paucity of introns could also suggest that 
LRRTM and NGR genes emerged by 
retrotransposition. Synteny analysis, however, 
reveals that at least LRRTM1-3 and NGRLs 
emerged by segmental chromosomal 
duplications (see below). 
  
The paucity of introns limits the opportunities 
for alternative splicing. As functional diversity 
can be generated by gene duplication or by 
alternative splicing, one could assume these 
processes to be functionally interlinked. 
Strikingly, by analyzing human and mouse 
genomes, Kopelman et al. found an inverse 
correlation between the size of a gene's family 
and its use of alternatively spliced isoforms 
(Kopelman et al. 2005). Thus, these seemingly 
disparate observations could offer a set of 
complementary explanations for the current 
LRRTM and NGR gene and gene family 
structure. 
 
LRRTM1, LRRTM2, and LRRTM3 genes in 
human and mouse are located within the 
largest intron of different α-catenin gene family 
members, and encoded by opposite strand of 
the DNA than the associated α-catenin genes. 
LRRTM4 seems to have arisen as the latest 
member of LRRTM family by smaller 
segmental duplication of ancestral LRRTM3 
locus, as it is clearly most closely related to 
LRRTM3 and is not located within an α-
catenin gene. 
 
This nested localization of LRRTM and α-
catenin genes clearly suggests and intriguing 
scenario of co-evolution by segmental 
duplication, and it also suggests that possibly 
transcriptional regulation between these gene 
pairs is interdependent. Nested gene pairs are 
relatively common in the human genome: 373 
such gene pairs have been reliably annotated; 
two-thirds of them are encoded by opposite 
strands of DNA (Yu et al. 2005). Interestingly, 
inverse correlation in the mRNA expression 
levels has been reported for the members of 
some nested gene-pairs (Yu et al. 2005; Seidl 
et al. 2006). This observation could be 
explained by transcriptional interference 
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between the partners (Yu et al. 2005). 
Research of this potentially important 
mechanism should receive more attention in 
the future, as the current mechanistic studies 
have been limited to Igf2r-Air non-coding RNA 
(ncRNA) gene cluster (Seidl et al. 2006).   
 
The evolutionary origin of the NGR family is 
more challenging to trace: Paralogous POV 
and serpin family genes flank NGR2 and 
NGR3 and NGR2 and NGR3 share functional 
(ligand-binding properties) and amino acid 
sequence similarities closer to each other 
compared to NGR1. All these suggest that 
segmental duplication of ancestral NGR2/3 
locus was the last duplication event in this 
gene family. 
 
 
 
4.2 Analysis of the primary, secondary 
and tertiary structure of the proteins 
encoded by LRRTM and NGR gene 
families  
 
Features of LRRTM and NGR proteins can be 
analyzed by bioinformatics. Each LRRTM 
gene encodes a protein with a signal peptide, 
ten LRRs, transmembrane segment, and a 
short region that, by bioinformatics, is localized 
in the cytoplasmic space. Protein structures of 
NgRs are highly related to those of LRRTMs: 
NgRs possess a signal peptide, eight LRRs, 
and a GPI-modification site that eventually 
anchors the mature proteins to the plasma 
membrane (Figure 3).  
  
 
 
 
 
 
 
Figure 3. Schematic structure of LRRTM and NgR family proteins. The different nomenclature suggested for NGR 
family members is shown. In this work the nomenclature suggested by (Barton et al. 2003) is used, except when 
specifically referring to the NgRL-subfamily. The alternative nomenclatures for NGR family were suggested around the 
same time by (Pignot et al. 2003) and in (II). NF and CF1, cysteine-containing amino- and carboxyl-terminal flanking 
domains, respectively. Extracellular (or ER/Golgi lumen) space is above and cytoplasmic space is below the depicted 
lipid bilayer. RTN4R, reticulon-4 receptor; HGNC, Human Genome Organization Gene Nomenclature Committee.  
 
 
 
 
 
 Results & Discussion  
      25 
 
 
 
 
 
 
human LRRTM1    451 KCFPASLRQLRQCFVTQRRKQKQKQTMHQMAAMSAQEYYVDYKPNHIEGALVIINEYGSCTCHQQPARECEV        522 
mouse LRRTM1    451 KCFPASLRQLRQCFVTQRRKQKQKQTMHQMAAMSAQEYYVDYKPNHIEGALVIINEYGSCTCHQQPARECEV        522 
human LRRTM2    446 KCCPPTLRRIRQCSMVQNHRQLRSQTRLHMSNMSDQGPYNEYEPTH-EGPFIIINGYGQCKCQQLPYKECEV        516 
mouse LRRTM2    445 KCCPPTLRRIRQCSMIQNHRQLRSQTRLHMSNMSDQGPYNEYEPTH-EGPFIIINGYGQCKCQQLPYKECEV        515 
human LRRTM3    443 KRYPASMKQLQQRSLMRRHRKKKRQSLKQMTPS-TQEFYVDYKPTNTETSEMLLNGTGPCTYNKSGSRECEV        513 
mouse LRRTM3    444 KRYPASMKQLQQRSLMRRHRKKKRQSLKQMTPG-TQEFYVDYKPTNTETSEMLLNGTGPCTYSKSGSRECEV        514 
human LRRTM4    448 KRYPASMKQLQQHSLMKRRRKKARESERQMNSP-LQEYYVDYKPTNSETMDISVNGSGPCTYTISGSRECEV        518 
mouse LRRTM4    448 KRYPASMKQLQQHSLMKRRRKKARESERQMNSP-LQEYYVDYKPTNSETMDISVNGSGPCTYTISGSRECEV        518 
                       *.::::::*  : :.:::   ::  :*     *  * :*:*.: *   : :*  * *.      :**** 
 
Figure 4. Predicted functional elements in the cytoplasmic segment of LRRTMs. Shown is the amino acid 
sequence alignment of intracellular parts of human and mouse LRRTMs. For LRRTM3 and LRRTM4 the short isoforms 
are shown. Identical amino acids are indicated with asterisks; physicochemically highly similar ones are indicated with 
colons; somewhat similar ones with dots. Putative dibasic ER-retention signals are highlighted on black background, as 
are the amino acids contributing to the putative ER-export motifs (di-acidic (commonly D/E-x-D/E) or di-hydrophobic 
(commonly FF/FY/LL/VV)). Identical ER-retention and ER-export signals are described earlier in the literature. Note 
that other LRRTMs also have sequences that are closely related to the marked ER-export and ER-import motifs. 
Putative protein kinase C (PKC) phosphorylation sites are marked on grey background, and putative protein kinase A 
(PKA) phosphorylation sites are underlined. Carboxyl-terminal motif resembling PDZ-protein binding motif is underlined 
as well. 
 
 
 
 
 
 
 
h-LRRTM1    522 V                                                                              52 
m-LRRTM1    522 V                                                                              522 
h-LRRTM2    516 V                                                                              516 
m-LRRTM2    515 V                                                                              515 
h-LRRTM3    513 V                                                                              513 
h-LRRTM3-l  513 IPLSMNVSTFLAYDQPTISYCGVHHELLSHKSFETNAQEDTMETHLETELDLSTITTAGRISDHKQQLA          581 
m-LRRTM3    514 V                                                                              514 
m-LRRTM3-l  514 IPLSMNVSTFLAYDQPTISYCGVHHELLSHKSFETNAQEDTMESHLETELDLSTITSAGRISDHKPQLA          582 
h-LRRTM4    518 V                                                                              518 
h-LRRTM4-l  518 MPHHMKPLPYYSYDQPVIGYCQAHQPLHVTKGYETVSPEQDESPGLELGRDHSFIATIARSAAPAIYLERIAN      590 
m-LRRTM4    518 V                                                                              518 
m-LRRTM4-l  518 IPHHVKPLPYYSYDQPVIGYCQAHQPLHINKAYEAVSIEQDDSPSLELGRDHSFIATIARSAAPAIYLERITN      590 
                :*  ::  .: :****.*.** .*: *   *.:*: : *:  .. **   * * *:: .* :     *    
 
Figure 5. Alternative carboxyl terminus of LRRTM3 and LRRTM4 proteins (“long isoforms”). Amino acid 
similarity is depicted as in Fig. 4. m, mouse; h, human. 
 
 
 
 
 
 
 
Homo sapiens        IPLSMNVSTFLAYDQPTISYCGVHHELLSHKSFETNAQEDTMETHLETELDLSTITTAGRISDHKQQLA* 
Macaca fascicularis IPLSMNVSTFLAYDQPTISYCGVHHELLSHKSFETNAQEDTMETHLETELDLSTITTAGRISDHKQQLA* 
Mus musculus        IPLSMNVSTFLAYDQPTISYCGVHHELLSHKSFETNAQEDTMESHLETELDLSTITSAGRISDHKPQLA* 
Rattus norvegicus   IPLSMNVSTFLAYDQPTISYCGVHHELLSHKTFETNAQEDTMESHLETELDLSTITSAGRIGDHKPQLA* 
Canis familiaris    IPLSMNVSTFLAYDQPTISYCGVHHELLSHKSFETNAQEDTMETHLETEVDLSTITTAGQISDHKQQLA* 
Gallus gallus       IPLAMNVSTFLAYDQPTISYCGVHHELLAHKAYNSNTQEEAVETHLETDLDLSTITTAARIKEHSQQLA* 
 
Figure 6. Alternative carboxyl terminal splice variant (“long isoform”) of LRRTM3 is conserved in evolution. 
Sequence comparison between several vertebrates is shown. TBLASTN-searches were used to identify homologous 
genomic sequences.   
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4.2.1 Analysis of the cytoplasmic segment 
of LRRTMs 
 
Several motifs could be identified in the 
cytoplasmic segment of LRRTMs by 
bioinformatics (Figure 4). Importantly, both 
ER-import and ER-export motifs could be 
identified, suggesting a complex regulation of 
intracellular trafficking. Different targeting 
signals could be masked or exposed at 
different times, as shown e.g. for NMDA 
receptor (Scott et al. 2001).  
 
I also present here an analysis of previously 
uncharacterized alternative splice variants of 
LRRTM3 and LRRTM4 that encode proteins 
with an alternative carboxyl terminus (Figure 
5). The presence of these long isoform splice 
variants is supported by several independent 
EST clones and full-length cDNA clones (e.g. 
GenBank entries BC111492 for human and 
BC113178 for mouse LRRTM3, and 
BC0373216 for mouse LRRTM4). These 
alternative transcripts have been conserved in 
evolutionary time-scale, as shown for LRRTM3 
in Figure 6. This further suggests the 
importance of the intracellular region of 
LRRTMs for their proper function and/or 
localization. 
 
 
4.3 Localization of LRRTM and NGR 
family mRNAs and proteins 
 
Tissue distribution of LRRTM and NGR family 
mRNAs was examined by RT-PCR and in situ 
hybridization. Transgene reporters were also 
utilized to study the expression of Lrrtm3 and 
Lrrtm1. Cellular level protein localization was 
studied by expressing LRRTM1 and various 
other expression constructs in non-neuronal 
cells and in neurons.  
4.3.1 mRNA expression pattern of mouse 
and human LRRTMs and NGRs  
 
In mouse brain, Lrrtm and NGR family 
members show somewhat similar mRNA 
expression profiles; importantly, all members 
of these gene families are robustly and 
predominantly expressed in the adult mouse 
brain. The mRNA expression of all members 
of these two gene families is also 
developmentally upregulated in the CNS, and 
it reaches steady-state levels within the first 
days after birth. However, each Lrrtm and 
NGR family member has unique, though 
partially overlapping mRNA expression pattern 
(e.g. in the hippocampus, cerebellum, and 
olfactory bulb the expression patterns differ 
dramatically). This implies that each member 
of these gene families might have partially 
non-redundant function(s) in the brain. The 
dramatic differences in expression patterns 
suggest that individual Lrrtm and NGR gene’s 
regulatory regions have been under significant 
selective pressure. Overall, the expression of 
Lrrtms and NGRs suggests that they function 
not only in the developing but also in the adult 
CNS. 
 
On the other hand, in organs other than brain, 
the mRNA expression profiles of these genes 
differ dramatically from each other: whereas 
mRNA expression of NGR family members is 
largely restricted to brain, Lrrtm1, Lrrtm4, and 
especially Lrrtm2 are also significantly 
expressed in other organs. This suggests that 
LRRTMs serve a cell biological role not unique 
to neurons and/or that they have multiple 
functions in different cell types.  
 
Since we found that the LRRTM1 locus is 
genetically linked to handedness and 
schizophrenia, we analyzed in further detail 
the expression of Lrrtm1 mRNA during 
development. In situ hybridization analysis of 
E12.5 and E15.5 mouse embryos revealed 
specific but widely distributed Lrrtm1 
expression in the developing CNS, including 
spinal cord, mesencephalon, pons, and 
developing forebrain. Although it remains 
unclear which brain regions are critical for the 
aforementioned human phenotypes, both 
handedness and schizophrenia originate 
during development. We found that at the 
above indicated developmental time points 
Lrrtm1 mRNA is expressed predominantly in 
post-mitotic neurons of the developing nervous 
system. Recently, Haines and Rigby reported 
that Lrrtm1 is also expressed in the neural 
progenitors of the E9 rostral neural tube 
(Haines and Rigby 2007). 
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4.3.2 LRRTMs and NGRs are expressed 
neuronally 
 
High magnification analysis of in situ 
hybridization samples revealed that Lrrtms and 
NGR family members are expressed 
selectively in neurons.  
 
Interestingly, in nearly all reported studies the 
CNS-expressed LRR-containing membrane 
proteins were found to be expressed in 
neurons. The known exceptions are OMgp, 
which is expressed in oligodendroglia-like cells 
(Huang et al. 2005), but also prominently in 
neurons (Habib et al. 1998). In addition, 
Lib/LRRC15 is expressed at least in astrocytes 
(Satoh et al. 2005).  
4.3.3 Subcellular localization of LRRTM1 
and NgR family members 
 
All NgR family members are transported to the 
plasma membrane, at least when 
overexpressed in non-neuronal cells (Barton et 
al. 2003). In contrast, I found that LRRTM1 is 
not transported to plasma membrane, but it 
co-localizes with ER-markers. When 
expression vector construct encoding myc-
LRRTM1 is transfected into E17 mouse 
cortical neurons or P18 rat DRG neurons, or 
into neuronal (neuro-2a), or non-neuronal 
(Cos-7) cell lines, no myc-immunoreactivity 
was detected on the plasma membrane. In 
contrast, in control experiments strong cell- set 
fort related neuronal LRR membrane protein 
myc-LINGO1 was observed (IV). 
 
In fixed and permeabilized Cos-7 cells myc-
LRRTM1 co-localized with ER-marker 
(dsRED2-ER). In neurons (P18 DRGs), 
LRRTM1 is localized to both the cell soma and 
to the neurites; in neurites it is also localized to 
lamellipodia of the growth cones (IV).  
 
Further supporting the intracellular localization 
of LRRTM1, when transfected into HEK293T 
cells, none of the six tested alkaline 
phosphatase (AP) fusion constructs containing 
LRR-domain of LRRTM1 in various 
constellations with AP, is secreted into 
conditioned media in detectable amounts, but 
they accumulate intracellularly. This result 
differs dramatically from the behavior of NgR1-
AP, NgR2-AP, NgR3-AP, and LINGO1-AP 
constructs (encoding LRR domain-AP fusion 
proteins) that, when transfected into cells, 
produce proteins that are avidly secreted into 
conditioned media (unpublished observation). 
  
The subcellular localization of LRRTM1 
suggests that LRRTM1 could control protein 
trafficking and thereby neuronal differentiation. 
In most reported studies, neuronal LRR 
membrane proteins have been found to be 
transported to the plasma membrane. In 
addition to LRRTM1, Pal is also localized 
intracellularly (Gomi et al. 2000). It should be 
noted that endogenous subcellular localization 
of most neuronal LRR membrane proteins is at 
best poorly characterized and nearly all data 
regarding intracellular localization is obtained 
by overexpressing the protein of interest. 
 
 
4.4 Mapping the NgR family 
interactome 
 
As a part of this thesis work, interactions 
between NgR family members and known 
NgR1 ligands were analyzed in detail. This 
study was prompted by a need to better 
understand the functions of NgR2 and NgR3, 
and to explore the possible redundancy in the 
signaling of myelin inhibitors of neurite growth. 
The molecular interactions were determined 
by using cell-based binding assays in 
combination with alkaline phosphatase 
conjugated ligands.  
4.4.1 Interactions between multiple 
reticulons and NgR1 
 
Reticulon-4/Nogo-A belongs to a four member 
reticulon family; the homology between family 
members is limited to the 200 amino acid 
reticulon (RTN) homology domain (RHD), 
which consists of a 66 amino acid hydrophilic 
sequence stretch flanked by two hydrophobic 
segments (Oertle et al. 2003). In addition to 
their neuronal expression, the high amino acid 
sequence similarity of the RHD between 
RTNs, and the high amino acid sequence 
similarity between different NgR family 
members, led us to propose earlier that 
different RTNs could interact with different 
NgR family members (II). I tested this 
hypothesis using AP-tagged forms of different 
RTN-66 regions, and found that RTN2-66 and 
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RTN3-66 interact with NgR1 with a similar low 
nM affinity than Nogo-66 (III).  
 
NGR1, Rtn2 and Rtn3 mRNA expression 
patterns in the brain are largely overlapping, 
and NGR1 is expressed in a sub-set of Rtn2 
and Rtn3 positive neurons (II). I also found 
that all Rtns are most prominently expressed 
in neurons. Thus the detected RTN2-66:NgR1 
and RTN3-66:NgR1 interactions could 
participate in neuron-to-neuron signaling or 
regulate neuronal formation and function in a 
cell-autonomous fashion.  
 
The detected RTN2-66:NgR1 and RTN3-
66:NgR1 interactions could also have a role in 
NgR1-mediated myelin inhibition of axonal 
growth. With this regard, I studied in detail the 
expression of all Rtn mRNA splice variants 
encoding proteins with RHD domains in the 
adult mouse spinal cord. I found that Rtn3 
mRNA is expressed in the same glial cell 
population of spinal cord white matter as 
Nogo-A mRNA (III). Thus it is possible that this 
detected molecular interaction has a role in 
myelin inhibition of neurite growth in the 
mouse spinal cord.  
 
Previously it has been noted that GST-RTN1-
66 and GST-RNT3-66 preparations do not 
cause collapse of developing chick sensory 
neuron’s growth cone in an in vitro assay. 
However, the functions of other RTN-66 
domains should be tested using other and 
more robust experimental paradigms of 
neuronal growth. The GST-fusion recombinant 
proteins used in the earlier studies could also 
be misfolded as ~95% were found to be 
insoluble. Nevertheless, these results thus 
suggest that RTN2-66 and RTN3-66 segments 
could antagonize Nogo-66 -induced NgR1 
signaling.  
 
4.4.2 MAG is a high affinity ligand for NgR2 
 
Similarly as above, I systematically studied the 
interactions between MAG and NgR family 
members. I found that MAG interacts not only 
with NgR1 but also with NgR2 (III). My results 
here are largely in agreement with earlier 
studies by Venkatesh et al. (Venkatesh et al. 
2005), who has also shown that MAG:NgR2 
interaction likely has a role in regulating 
neurite outgrowth in vitro. 
4.4.3 Characterization of OMgp-MAG 
interaction 
 
OMgp has also been reported to function as a 
high-affinity ligand for NgR1 (Wang et al. 
2002). I aimed to confirm and extend these 
observations by studying the possible 
interactions between OMgp and NgR family 
members. While I did not detect interaction 
between OMgp and NgR2 or NgR3, I did find 
that OMgp interacts with MAG (III). OMgp’s 
affinity to MAG is higher than its affinity to 
NgR1 (III).  
 
 
 
 
 
Figure 7. Summary of observed molecular 
interactions involving NgR family members. This 
schematic figure illustrates the proposed glia-to-neuron 
signaling mechanisms. Since no Rtn2 expression has 
been detected in glial cells, it is omitted from the figure, 
although it binds to NgR1. Not drawn in scale. Reprinted 
from (III).  
 
The reportedly low levels of OMgp expression 
in glial cells, and its prominent expression in 
neurons (Habib et al. 1998) suggests that a 
ternary complex consisting of OMgp, MAG and 
NgR1 could regulate specific aspects of 
oligodendrocyte-neuron-interactions. Neuronal 
OMgp could regulate glial cell functions by 
interacting and signaling via glial-cell 
expressed MAG as well. The summary of 
molecular interactions observed is provided in 
Figure 7.   
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4.5 Mechanistic insight into how NgR1 
interacts with multiple ligands  
 
How can NgR1 interact with such a high 
affinity with multiple structurally divergent 
ligands? To answer this question, I aimed first 
to map the nature of Nogo-A:NgR1 
interactions in more detail. Then we aimed to 
systematically map the binding sites of 
multiple myelin ligands in NgR1 using a NgR1 
alanine-mutant library consisting of NgR1 
expression constructs with one or multiple 
solvent-accessible surface residues mutated 
to alanine. The AP-fusion ligand cell-based 
binding assay is versatile and amenable for 
scaling up making it feasible to test multiple 
ligands with the extensive NgR1 mutant 
library. The construction as well as most of the 
analysis of NgR1 alanine-mutant library was 
done by Dr. Feghua Hu, and Joanna Chin and 
Ji Liao.  
4.5.1 Multiple sites in Nogo-A interact with 
NgR1  
 
Nogo-A does not have a signal sequence, and 
the mechanism how it is inserted into the 
oligodendrocyte lipid bilayer in unknown. The 
putative transmembrane/intramembrane 
domains in Nogo-A are of unusual length (35 
and 36 amino acids), suggesting that they may 
span the lipid bilayer twice. A recent report 
proposed that all three segments of Nogo-A 
are presented in cis on the same side of lipid 
bilayer (Voeltz et al. 2006). Most Nogo-A is 
present in the ER. Interestingly, as Nogo-A 
contains a carboxyl-terminal ER-retention 
signal, we reasoned that Nogo-A could escape 
ER retention by presenting this segment to the 
ER lumen/extracellular space. Thus, we 
sepculated that carboxyl-terminal amino acids 
of Nogo-A could also contribute to NgR1 
binding. I tested this hypothesis by preparing 
AP-fusion protein containing carboxyl-terminal 
39 amino acids of Nogo-A, and found that this 
segment of Nogo-A interacts with NgR1 with 
low nM affinity (III). For the schematic 
structure of Nogo-A indicating the 
nomenclature used, see Figure 8. 
 
   
Figure 8. Schematic structure of Nogo-A indicating 
the nomenclature used. The amino-terminus is left and 
the extracellular space is down. The three NgR1 binding 
segments are highlighted. Nogo-66 fragment binds to 
NgR1 with the highest affinity, whereas Nogo-A-24 and 
Nogo-C39 bind with somewhat lower affinity. The 
presented topology on the plasma membrane is 
consistent with the observations; the topology of Nogo-A 
on the plasma membrane has not been experimentally 
determined. It is possible that several conformations 
exist. Not drawn in scale; in vivo the amino terminal 
segment is ~x30 longer than carboxyl terminal segment. 
Reprinted from (III).  
 
4.5.2 Myelin ligands’ binding to NgR1 
requires overlapping but partially separate 
residues 
 
By using a library of 74 NgR1 mutants and AP-
fusion ligands (Nogo-66, Nogo-Y4C, Nogo-
C39, MAG, OMgp) the residues in NgR1 
critical for ligand binding were determined (III).  
 
A large number of alanine-substituted NgR1 
mutants bound all known ligands with similar 
affinity as wild-type NgR1. These residues 
were mostly located on the convex side of the 
NgR1. This suggests that the convex side is 
not a primary interface for known ligand-NgR1-
interactions. This is also the case in other 
determined LRR receptor-ligand -interactions 
(internalin:E-cadherin (Schubert et al. 2002); 
glycoprotein Ibα:von Willebrand factor 
(Huizinga et al. 2002)). 
 
A second set of NgR1 mutants lost the ability 
to bind all ligands completely. Interestingly, all 
of these residues are clustered on the middle 
of the concave side of NgR1’s LRR domain. 
This suggests that all ligands utilize this 
central binding region. It is possible that subtle 
differences in critical binding regions between 
different ligands do exist, but the resolution of 
the screen did not allow us to identify them.  
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Figure 9. Residues in concave side of NgR1’s LRR 
domain are critical for Nogo, MAG and OMgp 
binding. The model is based on the analysis of 74 
alanine substituted NgR1 mutants. Residues required for 
the binding of all three ligands (red), some ligands but 
not others (yellow), and not required for ligand binding 
(blue) are highlighted. Reprinted from (III). 
 
 
A third set of NgR1 mutants selectively lost the 
ability to bind some but not all ligands, either 
completely or partially. These residues were 
scattered largely around the central binding 
region defined by the second set of NgR1 
mutants (above). The model for ligand:NgR1 
interactions based on these results is 
presented in Figure 9. 
 
The identification of a central binding region in 
NgR1 shared by multiple ligands may facilitate 
the design and development of small molecule 
therapeutics blocking the binding of all NgR1 
ligands. This kind of general NgR1 antagonist 
might promote axonal regeneration after CNS 
injury. Projects to screen chemical libraries 
with the aim of identifying small molecules 
capable of blocking NgR1’s interactions with 
its ligands are ongoing at Dr. Strittmatter’s 
laboratory. 
 
It should be noted that as in nearly all 
molecular biology experimentation, the 
summary of binding data presented here is 
simply a model consistent with the current 
existing observations. The current gold 
standard in defining residues critical for 
protein-protein -interactions is to combine X-
ray crystallographic methods with confirmatory 
mutagenesis analysis. No crystal structures for 
NgR1 in complex with any of its ligands have 
been reported. However, several observations 
suggest that the presented model is relatively 
accurate. First, the alanine-mutated NgR1-
constructs included in the analysis were 
expressed in a similar fashion (similar 
expression level and plasma membrane 
localization) as wild-type NgR1. Second, a 
large collection of mutants did not disrupt the 
binding of any ligands further suggesting that 
mutagenesis in general is not detrimental to 
NgR1’s folding. Third, many NgR1 mutants 
lost ability to bind selectively to some, but not 
to all of the ligands. Thus the remaining 
binders provide an internal control that the 
overall folding of mutant NgR1 has occurred 
appropriately. With regard to the set of NgR1 
mutants that did not bind to any of the ligands, 
an argument can be set forth that these 
mutants are simply misfolded. However, the 
continuous coiling structure of the LRR domain 
provides no a priori reasons to assume that 
mutations in the central region of the concave 
side of LRR domain would be more 
detrimental to the folding of the LRR domain 
than mutations in the periphery of the concave 
region.  
 
 
4.6 Lrrtm1 and Lrrtm3 knock out mice 
as tools to pioneer in vivo studies on 
neuronal LRR membrane proteins 
 
During this thesis work Lrrtm1 and Lrrtm3 
knock out mice were generated. While more 
extensive characterization of these mouse 
lines is undergoing, a brief set of technical 
 Results & Discussion  
      31 
observations verifying a successful gene 
targeting as well as the functionality of reporter 
genes is provided below.  
4.6.1 Lrrtm1 and Lrrtm3 genes can be 
efficiently targeted 
 
Successful targeting of Lrrtm1 and Lrrtm3 
genes was verified by Southern blotting. 
Targeting strategy for the Lrrtm1 is shown in 
Figure 10. The absence of Lrrtm3 mRNA in 
then brain of an adult lrrtm3 knock out mouse 
is presented in Figure 11.  
 
 
 
 
 
 
Figure 11. RT-PCR analysis of adult Lrrtm3 knock 
out (-/-) and wild-type (+/+) brain mRNA. It 
demonstrates the complete removal of Lrrtm3 mRNA 
and the appearance of GFP reporter-gene mRNA 
transcript in the knock out mice. The mRNA expression 
of nested Ctnn3 gene is similar between the genotypes. 
Results are shown for two pairs of mice. aq, water 
control. 
 
 
 
 
 
 
 
 
Figure 10. Targeting strategy and Southern blotting results for Lrrtm1 locus.  In (A) part of wild-type lrrtm1 locus 
as well as the elements of the replacing cassette are shown. The locations of the restriction enzyme cleavage sites 
used for Southern blotting analysis are also indicated. The expected lengths of Southern blotting fragments obtained 
with 5´ and 3´ probes, when digesting the ES cell genomic DNA with the indicated restriction enzymes, are shown in 
(B). The obtained Southern blotting results with correctly targeted cell clone (+/-) and wild-type (+/+) cell clone are 
shown in (C). 
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4.6.2 tau-GFP and tau-LacZ reporter 
expression 
 
Brains of adult Lrrtm3 or Lrrtm1 heterozygous 
mice were used to analyze the expression of 
the reporter genes encoding either tau-GFP 
(Lrrtm3 knock out) or tau-LacZ (Lrrtm1 knock 
out). The observed results not only identify the 
terminal fields of Lrrtm3 and Lrrtm1 expressing 
neurons, but also largely corroborate the 
earlier in situ hybridization results: e.g. for 
Lrrtm1, prominent mRNA expression was 
observed in the mitral cell layer of the olfactory 
bulb, and prominent LacZ activity was 
detected in the presumed innervation target, 
piriform cortex (data not shown). For Lrrtm3, 
prominent mRNA expression was detected in 
the granular cell layer in the cerebellum; as 
expected, abundant GFP immunoreactivity 
was observed in the molecular layer (Figure 
12). 
 
Thus the reporter genes can be used to map 
the neuronal connections of Lrrtm1 and Lrrtm3 
expressing neurons in finer detail. While the 
LacZ reporter provided easy analysis, the GFP 
signal had to be visualized with anti-GFP 
antibodies (Chemicon) in combination with 
fluorescent or enzymatic secondary 
antibodies.  
4.6.3 On the phenotype of Lrrtm3 knock out 
mice 
 
Lrrtm1 and Lrrtm3 knock out mice are viable. 
Preliminary analysis of backcrossed Lrrtm3 
knock out mice suggests that their 
performance in test requiring motor co-
ordination (rotarod test) is compromised. This 
is in agreement with the extensive expression 
of Lrrtm3 mRNA in the cerebellum and basal 
ganglia. Among other tests performed Lrrtm3 
knock out mice were found to be less immobile 
in a test measuring depression-like behavior 
(Matti Airaksinen, Vootele Voikar, Juha 
Laurén, unpublished). 
 
 
 
Figure 12. Lrrtm3 mRNA expression (A) and Lrrtm3 
tau-GFP reporter expression in the adult mouse 
cerebellum. ML, molecular layer; GL, granular layer; 
asterisks denote Purkinje cell layer. Lrrtm3 mRNA 
expression pattern in the cerebellum was first published 
in (I); Fig. B kindly provided by Dr. Airaksinen.  
 
 
4.7 Association of LRRTM1 locus to 
schizophrenia and handedness 
 
Dr. Clyde Francks, the director of our 
collaborative study on the genetics of 
handedness, found a strong association 
between a 70 kb-spanning haplotype in the 
proposed promoter region of LRRTM1 gene 
and a quantitative measure of human 
handedness (P=0.00002), when the haplotype 
was paternally inherited. LRRTM1 is located 
within the previously identified 2p12-q11 
handedness gene candidate region. The 
predisposing haplotype (named as “2-2 
haplotype”) is composed of two SNP and has 
a 9% frequency in the Caucasian population 
(IV). Those who inherit the “2-2 haplotype” 
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were more likely to become left-handed than 
those who inherit some other haplotype. 
 
By analyzing 1002 families of European origin 
affected with schizophrenia, Dr. Francks also 
found that the same LRRTM1 haplotype 
predisposes to schizophrenia (P=0.0014), 
when paternally inherited (IV). Consistent with 
paternal association, in humans LRRTM1 may 
be an imprinted gene with a variable pattern of 
maternal down-regulation. In summary, our 
association data suggests that allelic variation 
upstream of LRRTM1 on the active paternal 
chromosome may affect LRRTM1 expression 
and play a role in the development of left-right 
brain asymmetry. 
4.7.1 No association of LRRTM1 gene 5´ 
region to schizophrenia in Han Chinese 
families 
 
After observing that the “2-2 haplotype” is 
associated with schizophrenia in Caucasian 
family samples, we wanted to test the possible 
association of the same haplotype with 
schizophrenia in Han Chinese schizophrenia 
samples. These biomaterials (DNA samples of 
1151 individuals) and schizophrenia data were 
originally collected in three projects 
participating in the National Institute of Mental 
Health (NIMH) Schizophrenia Genetics 
Initiative. 
 
The scatter diagram classifying the PCR 
products, and hence the genotypes, 
demonstrates clearly distinguishable SNP 
base calling results in nearly all cases (Figure 
13). The sequences of the primers use in the 
genotyping are shown in Table 7. Mendelian 
inheritance of the observed genotypes was 
verified, and families with non-Mendelian 
inheritance pattern were removed from the 
analysis. In total, one family was removed 
from the analysis of rs723524 SNP and five 
from the analysis of rs1446109 SNP. These 
inconsistencies were from errors in 
genotyping, or errors in identifying the 
biological father of the offspring. The number 
of families removed from the analysis has a 
negligible effect on the statistical analysis.  
 
For the analysis, a transmission disequilibrium 
test (TDT) was used. This test looks at all 
heterozygous parents and scores which alleles 
are transmitted to affected offspring. A 
deviation from 50-50 transmission of the 
alleles, summed across all families, would be 
indicative that the SNP or haplotype is 
associated with the disease – either causally 
related to the disease, or in linkage 
disequilibrium with a nearby causal variant. As 
we were testing a hypothesis related to an 
imprinted gene, we tested paternal and 
maternal transmission separately. The 
statistical analysis was mostly performed by 
Dr. Clyde Francks. 
 
We did not find evidence for paternal over-
transmission of the risk haplotype to 
schizophrenia patients or any other 
association of schizophrenia to this locus in 
Han Chinese population (Tables 8-10). This 
suggests that the LRRTM1 “2-2 haplotype”, 
that is associated with schizophrenia in 
Caucasian samples, is not associated with 
schizophrenia in Han Chinese population.  
 
It is plausible that ethnic groups of different 
genetic composition have, due to population 
bottleneck effects, unique collections of 
different gene variants that predispose to 
schizophrenia. Alternatively, the LRRTM1 
locus might be associated with schizophrenia 
in Han Chinese population, but the 
predisposing haplotype could be determined 
by different SNPs. To clarify this matter, more 
extensive genotyping should be performed to 
define the main genetic variations in this locus 
in Han Chinese population, and to determine if 
some other haplotype is associated to 
schizophrenia. 
 
In the Caucasian population, the rare alleles of 
SNPs rs1446109 and rs723524 have each 
~10% frequency. In the Han Chinese 
population the rare alleles had ~25% and 
~35% frequency, respectively. This pattern is 
consistent with HapMap data; allele frequency 
differences of this magnitude are common 
between populations (HapMap_Consortium 
2005).   
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Figure 13. Scatter diagram classification of the PCR products. The fluorescent dyes detected are indicated on the 
X and Y-axis. The cut-off limits used are depicted by horizontal and vertical lines. For example, for rs723525 samples 
in the upper left quadrant are homozygous for allele 2, samples in the upper right quadrant are heterozygous, and 
samples in the lower right quadrant are homozygous for allele 1. The PCR-reaction did not produce a detectable 
amplicon for the samples in the lower left quadrant.  
 
 
 
 
 
 
 
SNP ref # Assay context sequence 
rs723524 TACATGACTTGATCATGTGCAGAAT[G/T]ATAGGGAAATATATTTCCAACACAG
rs1446109 TACATAATGCCAAATTGTCATCCTG[A/G]AAGATTTCACACTTTTCATCCTCAA 
 
Table 7. Sequences of the primers used in the genotyping. The primers labeled with VIC and FAM differed in one 
nucleotide (in brackets), and hence specifically amplify only one of the SNP variants.      
 
 
 
 
 
   Paternal Maternal Combined 
 N % TR NT Chi2 TR NT Chi2 TR NT Chi2 
rs1446109.1 799 74.5 95 84 0.68 73 78 0.17 210 204 0.09 
rs1446109.2 273 25.5 84 95 0.68 78 73 0.17 204 210 0.09 
 
Table 8. Transmission data for locus rs1446109.  N, number of individuals with allele “.1” [=A] or “.2” [=G]. %, 
percentage of individuals with allele “.1” or “.2”. TR, number of times allele is transmitted to affected individual. NT, 
number of times allele is not transmitted to affected individual. Chi2 is a statistical measure reporting the likelihood that 
the observed distribution differs from what is expected under random inheritance model. Analysis was performed for 
paternal, maternal and overall inheritance. For example allele “.2” of rs1446109 has 25.5% frequency and it was 
transmitted by heterozygous fathers to affected offspring 84 times in the sample, and not transmitted 95 times. This is 
not significantly different from what could be expected by chance. 
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   Paternal         Maternal Combined 
 N % TR NT Chi2 TR NT Chi2 TR NT Chi2 
rs723524.1 692 64.9 89 81 0.38 91 89 0.02 233 223 0.22 
rs723524.2 374 35.1 81 89 0.38 89 91 0.02 223 233 0.22 
 
Table 9. Transmission data for locus rs723524. Allele “.1” is [G] and allele “.2” is [T]. 
 
 
 
 
 
 
   Paternal         Maternal Combined 
 N % TR NT Chi2 TR NT Chi2 TR NT Chi2 
Haplotype 1 582 59.1 106 87 1.87 93 98 0.13 213 199 0.48 
Haplotype 2 177 18.0 65 78 1.18 66 62 0.12 141 150 0.28 
Haplotype 3 158 16.1 54 57 0.08 59 64 0.20 117 125 0.26 
Haplotype 4 67 6.8 31 34 0.14 28 22 0.72 59 56 0.08 
 
Table 10. Transmission data for haplotypes formed by alleles extending from rs1446109 to rs723524. 
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5 CONCLUDING REMARKS  
 
This study characterizes evolutionary origins 
and expression pattern of six previously 
uncharacterized genes: LRRTM1-4 and 
NGRL2-3. These genes encode proteins 
belonging to the neuronal LRR membrane 
protein family. LRRTM and NGRL mRNAs are 
prominently expressed in the human and 
mouse brain, and they possess partially non-
overlapping expression patterns. When 
overexpressed, all NgR family members are to 
a significant degree transported to the plasma 
membrane. Interestingly, at least LRRTM1 is 
localized intracellularly in all cell types tested 
when overexpressed.  
 
While this thesis work was being completed, a 
whole collection of other studies addressing 
the structure and functions of other neuronal 
LRR membrane proteins was also published. 
The emerging picture is that neuronal LRR 
membrane proteins play a role in neurite 
growth regulation, synapse formation, and in 
the regulation of growth factor signaling. This 
alone justifies future detailed studies on the 
function of these genes. The knock out mouse 
lines that were developed as a part of this 
thesis work will undoubtedly be useful. 
 
This study clarifies several important aspects 
on ligand binding to NgR1, and defines new 
high-affinity molecular interactions: I found that 
three separate segments of Nogo-A interact 
with NgR1, and that RTN2-66 and RTN3-66 
interact with NgR1 as well. Since I observed 
that all RTNs are most prominently expressed 
in the neurons, 66 amino acid loops of RTNs 
2, 3, and 4 could interact with NgR1 in cis in 
neurons. However, RTN3 mRNA splice variant 
encoding protein with the RHD was also 
detected in the glial cells of the adult mouse 
spinal cord. Thus RTN3-66 could have a role 
in myelin inhibition of neurite growth.  
 
The extensive NgR1 mutagenesis study 
defined a central region on the concave side of 
NgR1 that is critical for the binding of Nogo-66, 
MAG, and OMgp. This compact core binding 
region might be amenable to pharmacological 
interventions.  
 
With regard to LRRTM1, our association data 
suggests that allelic variation upstream of 
LRRTM1 may affect the gene's expression on 
the active paternally inherited chromosome. 
This altered gene expression might be 
relevant to the formation of brain asymmetry. 
LRRTM1 is the first identified potential genetic 
influence on human handedness, and the 
second putative gene involved in human brain 
asymmetry. How LRRTM1 might affect brain 
development at certain locations and time 
points remains as an important open question.  
 
Since schizophrenia is associated to left-
handedness, we studied the association of 
LRRTM1 “2-2 haplotype” with schizophrenia. 
We found that LRRTM1 “2-2 haplotype” is 
associated with schizophrenia in certain 
Caucasian populations, but not among Han 
Chinese. Schizophrenia, like handedness and 
brain asymmetry, is an etiologically complex 
trait with many genetic and environmental 
influences.  
  
6 FUTURE DIRECTIONS 
 
The overall role of Nogo-66 Receptor is not 
dramatically clearer today than what it was at 
the time of its discovery in 2001, when it was 
postulated that “Disruption of the interaction 
between Nogo-66 and its receptor provides 
the potential for enhanced recovery after 
human CNS injury” (Fournier et al. 2001). In 
vitro experiments have revealed a growing list 
of proteins or protein fragments that bind to 
NgR1 with nanomolar-level affinity. Currently, 
proteins or protein fragments known to bind to 
NgR1 with very high affinity are Nogo-66, 
RTN2-66, RTN3-66, Nogo-Y4C, Nogo-C39, 
MAG, OMgp, p75, Taj/TROY, Lingo1, Abeta1-
42, FGF-2 (Dr. Roman Giger, Society for 
Neuroscience meeting abstract, 2006), and 
three currently unpublished proteins identified 
in Dr. Strittmatter’s laboratory. The full 
biological importance of all these interactions 
should be evaluated in the future experiments.  
 
Technical challenges in efficiently introducing 
and down-regulating genes in primary neuron 
cultures as well as those in generating highly 
specific and potent preparations of myelin 
inhibitors of axonal growth are significant. 
However, with time a more informed 
consensus regarding the role and importance 
of Nogo-66, NgR1, and the proposed co-
receptors in myelin inhibition of neurite growth, 
will likely emerge.  
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More research is needed to address the 
physiological role of the high affinity interaction 
between MAG and OMgp that I described in 
this work.   
 
Future studies on the roles of LRRTM1 in 
mammalian brain development may reveal 
new insights into one of the major 
uncharacterized processes in developmental 
biology, the establishment of the left-right brain 
axis. Defects in LRRTM1 function could 
potentially lead to maldevelopment of left-right 
asymmetry. Thus variation in the LRRTM1 
locus might have a role in not only 
schizophrenia but also in other 
neuropsychiatric disorders. 
 
The Lrrtm1 knock out mice that I made as a 
part of this thesis work can be used to i) study 
in vivo functions of LRRTM1; ii) study the 
mechanisms that lead to left-right brain 
asymmetry; and iii) gain insight into the 
etiology of schizophrenia by analyzing the 
possible schizophrenia-associated behavioral 
disturbances in these mice.  
 
First, the expression of Lrrtm1 in the 
developing mouse CNS should be analyzed in 
detail by utilizing the tau-LacZ reporter gene. 
 
Second, whether Lrrtm1 knock out mice 
exhibit behavioral disturbances or 
endophenotypes that are potentially relevant 
to signs and symptoms of schizophrenia (such 
as psychomotor agitation, sensitivity to 
psychotomimetic drugs, social withdrawal, 
disturbed working memory and spatial 
learning, deficits in attention/sensorimotor 
gating; for review, see (Powell and Miyakawa 
2006)) should be examined in detail.  
 
Third, to assess whether Lrrtm1 knock out 
mice exhibit abnormally strongly or weakly 
lateralized paw preference, the strength of 
lateralization of paw-preference (i.e. how 
consistently using the same forepaw) should 
be studied using established pellet-reaching 
assays (Collins 1968). 
 
Finally, to mechanistically understand how 
variation in the LRRTM1 locus might partially 
determine handedness in humans, detailed 
studies on CNS development in the Lrrtm1 
knock out mice should be performed.  
 
Left-right brain asymmetry could result from 
differential timing of key developmental events 
in contrasting hemispheric regions. In a 
simplified form, brain asymmetry could be 
caused by a delay in mitotic exit of neuronal 
progenitor cells in either side of the brain. This 
would allow more neurons to emerge in that 
hemispheric structure. Alternatively, it is also 
plausible that differential timing in cortical 
maturation facilitates certain regions of the left 
or right side of the cerebral cortex to form 
functionally preferred thalamocortical 
connections, which would impose different 
functional identities on the otherwise 
equivalent cortical regions in the left and right 
hemispheres.  
 
To determine the possible role of Lrrtm1 in 
controlling neuronal mitotic exit, migration and 
size of key brain structures (most importantly 
the cerebral cortex and its layers) in Lrrtm1 
knock out mice should be determined and 
compared to wild-type control mice. This 
analysis can be complemented by determining 
neuronal cell density. The quantity and 
anatomical destiny of neurons born during 
given developmental time points should be 
assessed by 5-bromo-2´-deoxyuridine (BrdU) 
labeling. The neuronal morphology in Lrrtm1 
knock out brain could be studied in situ e.g. by 
crossing Lrrtm1 knock out mice with Thy-1-
EGFP transgenic line, which expresses GFP 
in a subset of neurons thereby enabling 
detailed studies on axonal, dendritic and spine 
morphology by confocal microscopy.  
 
A recent study found that LRRTM3 promotes 
processing of amyloid precursor protein (APP) 
by BACE1 (Majercak et al. 2006). This finding 
is especially significant as it came from a 
systematic RNAi screening of 15 200 genes 
for their role in Aβ42 secretion. Majercak et al. 
also noted that LRRTM3 maps to a 
chromosome 10 locus linked to late-onset 
Alzheimer’s disease and elevated plasma 
Aβ42 levels in humans. However, the study by 
Majercak et al. was based exclusively on in 
vitro experiments. To assess the gene’s 
proposed role in Alzheimer’s disease 
pathogenesis, in vivo experiments using 
Lrrtm3 knock out mice are now much looked 
after. 
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